DNA polymerase mutants with enhanced template discrimination activity.

Abstract

To provide mutant Taq DNA polymerases having enhanced template discrimination activity compared with the unmodified Taq DNA polymerases.SOLUTION: This invention relates to mutant DNA polymerases having enhanced template discrimination activity compared with the corresponding unmodified DNA polymerase counterparts, where the amino acid sequence of the mutant DNA polymerase includes at least one substitution at residue positions structurally and functionally homologous or orthologous to position 783 or 784 of an unmodified Taq DNA polymerase.SELECTED DRAWING: None

Description

[Technical field]

[0001] This application claims the benefit of priority under 35 U.S.C. § 119 of U.S. Provisional Patent Application No. 61 / 904,335, filed November 14, 2013, entitled "DNA POLYMERASE MUTANTS WITH ENHANCED TEMPLATE DISCRIMINATION ACTIVITY," the entire contents of which are incorporated herein by reference.

[0002] The present invention relates to mutant DNA polymerases with enhanced primer and / or template discrimination activity and their use for polymerase-based assays for genetic diagnostic analysis. [Background technology]

[0003] The ability to accurately diagnose a given genetic condition and predictably treat genetic diseases requires reliable methods for accurately determining gene sequence information. Many genetic diseases are associated with single nucleotide polymorphisms (SNPs) in genes that code for proteins. The presence of SNPs associated with genetic diseases, such as cancer, can be difficult to detect due to the small number of genetically altered cells in a population that code for one or more alleles ("low frequency alleles").

[0004] Polymerase-based assays such as the polymerase chain reaction (PCR) have a significant impact and widespread use in genetic diagnostics and molecular medicine. Polymerases synthesize DNA sequences by the addition of nucleotides to the 3' end of short oligonucleotides (hereafter abbreviated as "primers"). The primers are hybridized to the single-stranded sequence ("template") that is to be amplified. DNA polymerase catalyzes the formation of a phosphodiester bond between the 3'-oxygen at the 3' end of the primer and an incoming deoxynucleoside triphosphate ("dNTP"). This chemical reaction ("primer extension") adds a nucleotide to the primer (e.g., the nascent growing DNA strand). Primer extension is base-specific in that a deoxynucleoside triphosphate that is complementary to a base in the template is added to the primer. The fidelity of DNA polymerase enzymes is very high and the rate of mutations introduced into the replicated DNA strand is low; however, the exact error rates vary between different DNA polymerase enzymes, and these rates are well characterized. The extension reaction can be repeated until the end of the template is reached.

[0005] Most polymerase-based assays for detecting SNPs rely on the polymerase enzyme discrimination between at least two different substrates. The first substrate contains the desired SNP to be detected; the second substrate contains normal nucleotides that should not be detected. Polymerase-based discrimination can be achieved by providing the first substrate as the preferred polymerase-competent substrate for the assay. This discrimination can be maximized to the extent that the first substrate is the only polymerase-competent substrate for the assay.

[0006] Many strategies are known in the art to establish conditions that support polymerase-based discrimination in substrates with minimal nucleotide differences, such as those that contain only a single nucleotide difference. One strategy relies on the ability of the polymerase to not efficiently initiate synthesis on substrates that lack the 3'-paired nucleotide of the primer. The design of an allele-specific primer is one in which the 3'-nucleotide forms a perfect match with a complementary base at the location containing the SNP-containing allele, and forms a mismatch pairing when annealing to an allele that lacks the SNP. The primer:template for the SNP-containing allele serves as a preferred polymerase-competent substrate, since the polymerase can efficiently initiate prime synthesis from such substrates. Examples of these strategies are described in Chen et al., "Single nucleotide polymorphism genotyping: biochemistry, protocol, cost and throughput," Pharmacogenomics J., 3(2):77-96 (2003); Kwok et al., "Detection of single nucleotide polymorphisms," Curr. Issues Mol. Biol. 5(2):43-60 (April 2003); Shi, "Technologies for individual genotyping: detection of genetic polymorphisms in drug targets and disease genes," Am. J. Pharmacogenomics 2(3):197-205 (2002); and Kwok, "Methods for genotyping single nucleotide polymorphisms," Annu. Rev. Genomics Hum. Genet., 2:235-58 (2001). A strategy to improve the selectivity of this class of allele-specific PCR primers is to introduce a second mutation at the penultimate base adjacent to the 3'-terminal nucleotide of the primer (i.e., adjacent to the SNP site).As before, the 3'-terminal residue is either matched or mismatched to the base being interrogated in the sample nucleic acid (SNP), but here the primer has either two adjacent mismatches to the target (both the 3'-terminal base and the penultimate base) or one mismatch to the target (only the penultimate base, the 3'-terminal base is a match). See, e.g., Newton et al., "Analysis of any point mutation in DNA. The amplification refractory mutation systems (ARMS)," Nucleic Acids Res., 17(7):2503-15 (1989). Yet another strategy to improve selectivity for this class of allele-specific PCR primers is to employ chemically modified nucleic acid residues at the 3'-end of the primer, such as locked nucleic acids (LNAs), which reduce the ability of DNA polymerases to initiate DNA synthesis from the 3'-terminal mismatch. See, e.g., Latorra et al., "SNP genotyping using 3' locked nucleic acid (LNA) primers," Human Mut., 22(1):79-85 (2003).

[0007] Template substrate discrimination can be increased in polymerase-based assays by requiring the second nucleic acid enzyme-catalyzed formation of one or more primers for use in the polymerase-based assay. In one such assay, the ligase chain reaction assay, DNA ligase is used with a polymerase to detect templates containing SNPs. Because polymerase-based assays require primers with a minimum length to hybridize to the template substrate, DNA ligase can be used to generate primers for the polymerase from oligonucleotides of suboptimal length. This assay relies on hybridizing two probes directly across the SNP polymorphic site, so that ligation can occur if the probes are identical to the target DNA. Two probes are designed: an allele-specific probe that hybridizes to the target DNA such that the 3' base is positioned directly across the SNP nucleotide, and a second probe that hybridizes to the template downstream of the complementary strand of the SNP polymorphic site to provide the 5' end for the ligation reaction. If the allele-specific probe matches the target DNA, it will hybridize perfectly to the target DNA and ligation can occur. Ligation generally does not occur in the presence of a mismatched 3'-base. Once the oligonucleotide product is formed, it can serve as a primer or as a template for polymerase-based assays. Examples of this strategy are described in Barany F., "Genetic disease detection and DNA amplification using cloned thermostable ligase.", Proc Natl Acad Sci USA., 1991 Jan, 1;88(1):189-93, and Wiedmann M., Wilson WJ, Czajka J., Luo J., Barany F., Batt CA, "Ligase chain reaction (LCR)--overview and applications.", PCR Methods and Applications 1994 Feb;3(4):S51-64.

[0008] RNase H-based PCR (rhPCR) can be used to improve polymerase-based discrimination because polymerase-competent substrates require primer:template with an available 3'-hydroxyl group on the primer, another strategy known in the art. The rhPCR method utilizes RNase H enzyme to convert primers that lack a 3'-hydroxyl group ("blocked primers") or that are otherwise non-functional and unable to support PCR into primers that contain a 3'-hydroxyl group ("unblocked primers") that can support PCR. Blocked primers in rhPCR include oligonucleotides that function as cleavage sites and oligonucleotides with blocked 3'-ends or other modifications that prevent either priming or template function of internal RNA residues. Type II RNase H recognizes annealed primer:template duplexes containing these blocked primers and cleaves the primer strand 5' of the RNA residue to generate a 3'-hydroxyl group at the adjacent DNA residue. Because RNase H enzymes do not cleave substrates containing unpaired RNA residues at the mismatch site, allele-specific template discrimination can be achieved by placing an RNA residue at a position complementary to the SNP on the selected allele template. The resulting type II RNase H cleavage product can serve as a polymerase-competent substrate.This enzyme cleavage strategy, similar RNase H strategies, and methods for blocking primer extension or inhibiting template function, thereby rendering PCR nonfunctional, are described in U.S. Patent No. 7,112,406 by Behlke et al., entitled "POLYNOMIAL AMPLIFICATION OF NUCLEIC ACIDS"; U.S. Patent No. 5,763,181 by Han et al., entitled "CONTINOUS FLUOROMETRIC ASSAY FOR DETECTING NUCLEIC ACID CLEAVAGE"; U.S. Patent No. 7,135,291 by Sagawa et al., entitled "METHOD OF DETECTING NUCLEOTIDE POLYMORPHISM"; U.S. Patent Application No. 20090068643 by Behlke and Walder, entitled "DUAL FUNCTION PRIMERS FOR AMPLIFYING DNA AND METHODS OF USE"; and U.S. Patent Application No. 20090068643 by Behlke and Walder, entitled "RNASE H-BASED ASSAYS UTILIZING MODIFIED RNA CLEAVE GENERATIONS FOR GENERAL USE"; No. 20100167353 to Walder et al., entitled "MONOMERS."

[0009] This field has focused on substrate-based approaches, such as those exemplified above, to improve the detection of genetic differences and low-frequency alleles. So far, the sensitivity of polymerase-based assays remains limited by the formation of non-specific amplification products that arise from ectopic or aberrant primer-related extension products unrelated to the desired template. The inherent reactivity of polymerases appears to be largely responsible for the generation of such artifacts during amplification.

[0010] Any further improvement in mismatch discrimination may therefore require modified polymerase enzymes endowed with inherently better 3'-nucleotide discrimination when used with one or more of the described strategies. Modified polymerase enzymes with different activity than the unmodified form can be prepared by chemical or enzymatic modification of the protein or by mutagenesis of the corresponding gene encoding the protein. In general, the latter approach is preferred due to the fact that genetically modified genes encoding a given mutant protein can be stably maintained, expressed and purified to obtain enzyme preparations with well-characterized properties.

[0011] Although unbiased mutagenesis strategies can be used to generate libraries of mutant polymerase genes, this approach has certain drawbacks. Millions of mutant enzymes must be screened for activity, and success often relies on the probability that effective mutations are present in the limited pool generated by random mutagenesis. Direct genetic selection methods are not sensitive enough to identify mutations associated with a second function besides the essential polymerase activity. The majority of mutant polymerase genes in a positive selection assay likely code for proteins that retain the functional attributes of a normal polymerase enzyme. Therefore, a secondary screening procedure using biochemical assays must be performed to identify whether any mutant polymerases have the desired activity. Despite the technical difficulties of setting up the initial selection process, the associated costs associated with performing secondary screening using biochemical assays are high when more than 100 clones need to be purified and assayed.

[0012] Another approach is to apply a biased mutagenesis strategy that specifically targets preselected regions of genes involved in function. In this approach, gene regions are first identified by a selection method. One such selection method is the comparative phylogenetic analysis of specific genes required in organisms of diverse origins. The principle of comparative phylogenetic analysis is premised on the hypothesis that diverse organisms do not share protein coding sequences in essential genes if they are not evolutionarily constrained for reasons related to essential protein function.

[0013] Phylogenetic comparative analysis of genes encoding DNA polymerases can provide insight into possible amino acid residues important for polymerase function. The overall folding pattern of DNA polymerases resembles the human right hand and includes three distinct subdomains: palm, fingers, and thumb. (See, e.g., Beese et al., Science 260:352-355, 1993; Patel et al., Biochemistry 34:5351-5363, 1995). Although the structure of the fingers and thumb subdomains varies widely among polymerases that differ in size and cellular function, the catalytic palm subdomains are all superimposable. For example, motif A, which interacts with incoming dNTPs and stabilizes the transition state during chemical catalysis, can be superimposed with a mean square root deviation of about 1 angstrom in mammalian polα and prokaryotic polI family DNA polymerases (Wang et al., Cell 89:1087-1099, 1997). Structurally, motif A begins with an antiparallel β-strand containing mainly hydrophobic residues followed by an α-helix. The primary amino acid sequence of DNA polymerase active sites is exceptionally conserved.

[0014] In addition to being well conserved, the active site of DNA polymerases has also been shown to be relatively flexible and capable of accepting certain amino acid substitutions without significantly reducing DNA polymerase activity. (See, e.g., U.S. Pat. No. 6,602,695.) Such mutant DNA polymerases can provide a variety of selective advantages in diagnostic and research applications, including, for example, nucleic acid synthesis reactions. The present inventors identify mutations in protein sequences using a single-letter amino acid code and an integer indicating the position of the mutation from the beginning of the protein sequence. Single-letter amino acid codes are well known in the art and are described, for example, in Stryer et al., Biochemistry, 5 th ed., Freeman and Company (2002). As an example, an aspartic acid ("D") is changed to a glycine ("G") in the D580G mutant, which is located 580 amino acids from the beginning of the protein sequence.

[0015] Reichert et al. performed a comparative phylogenetic analysis of thermoactive DNA polymerases from thermophilic bacteria, in which the protein coding sequences of DNA polymerase I enzymes were aligned for 13 phylogenetically distinct species. The analysis revealed that eight amino acid positions within a 15 amino acid long motif located at amino acid positions 645-685 (Thermus sp. Z05 DNA polymerase ("Z05 DNA polymerase")) could tolerate change without compromising the function of the core enzyme.

[0016] Comparative phylogenetic analysis does not provide specific functional information related to non-conserved amino acids, rather it suggests that non-conserved amino acids are not likely important for core enzyme function. Therefore, specific mutations were introduced into a recombinant gene encoding a mutant of Z05 DNA polymerase ("Z05 D580G polymerase"), and the resulting Z05 D580G polymerase mutants were screened for their ability to confer a reduced ability to extend oligonucleotide primers with 3'-mismatches to templates. Reichert et al. found that one such mutant Z05 D580G V667E polymerase exhibited better discrimination (about 2-fold) than the parent Z05 D580G polymerase. See U.S. Patent Application No. 2012 / 0015405 by Reichert et al., entitled "DNA POLYMERASES WITH INCREASED 3'-MISMATCH DISCRIMINATION."

[0017] Comparative phylogenetic analysis has limitations with regard to identifying DNA polymerase activities that exhibit improved 3'-nucleotide discrimination. This is due to the fact that all DNA polymerases of a given enzyme class face similar template substrates and nucleotide pools across a spectrum of phylogenetically diverse organisms. Given the fact that all DNA polymerases must exhibit 3'-nucleotide mismatch discrimination to preserve high fidelity replication of daughter template strands, it is not surprising that comparative phylogenetic analysis can be applied to identify possible amino acid positions that may affect mismatch discrimination. What is needed is to identify DNA polymerases with improved 3'-nucleotide discrimination for template substrates with distinct 3'-end modifications that are exhibited by the polymerase only in biochemical assays, such as those used in some PCR-based assays for low-frequency allele detection.

[0018] Taq DNA polymerase is an enzyme discovered in Thermus aquaticus bacteria (Chien, A. et al., J Bacteriol., 1976, 127:1550-1557). The enzyme is classified as a deoxyribonucleic acid polymerase, class I (enzyme code, EC 2.7.7.7). Its catalytic activity is to amplify DNA sequences. The peptide and gene sequences of Taq DNA polymerase enzyme isolated from nature are well known in the art and are listed in Table 1 (Lawyer, FC et al., J. Biol. Chem., 1989, 264:6427-6437; Genbank database ID J04639.1).

[0019] [Table 1] TIFF0007640606000002.tif228159

[0020] Taq DNA polymerase extends primers composed of deoxyribonucleotides, however, some chemical modifications of the primer are tolerated and do not significantly reduce the efficiency of the primer extension reaction. For example, if the nucleotide at the 3' primer end is a ribonucleotide instead of a deoxyribonucleotide, Taq DNA polymerase can extend such a primer with considerable efficiency and speed. [Prior art documents] [Patent documents]

[0021] [Patent Document 1] U.S. Pat. No. 7,112,406 [Patent Document 2] U.S. Pat. No. 5,763,181 [Patent Document 3] U.S. Patent No. 7,135,291 [Patent Document 4] US Patent Application Publication No. 2009 / 0068643 [Patent Document 5] U.S. Patent Application Publication No. 2010 / 0167353 [Patent Document 6] U.S. Patent No. 6,602,695 [Patent Document 7] U.S. Patent Application Publication No. 2012 / 0015405 [Non-Patent Document]

[0022] [Non-Patent Document 1] Chen et al., "Single nucleotide polymorphism genotyping: biochemistry, protocol, cost and throughput", Pharmacogenomics J., 3(2): 77-96 (2003) [Non-Patent Document 2] Kwok et al., "Detection of single nucleotide polymorphisms", Curr. Issues Mol. Biol. 5(2): 43-60 (April 2003) [Non-Patent Document 3] Shi, "Technologies for individual genotyping: detection of genetic polymorphisms in drug targets and disease genes", Am. J. Pharmacogenomics 2(3): 197-205 (2002) [Non-Patent Document 4] Kwok, "Methods for genotyping single nucleotide polymorphisms", Annu. Rev. Genomics Hum. Genet., 2: 235-58 (2001) [Non-Patent Document 5] Newton et al., "Analysis of any point mutation in DNA. The amplification refractory mutation systems (ARMS)", Nucleic Acids Res., 17(7): 2503-15 (1989)

Non-Patent Document 6

Non-Patent Document 7

Non-Patent Document 8

Non-Patent Document 9

Non-Patent Document 10

Non-Patent Document 11

Non-Patent Document 12

[0023] Summary of the Invention In one embodiment, a mutant Taq DNA polymerase is provided that has enhanced template discrimination activity compared to unmodified Taq DNA polymerase. The amino acid sequence of the mutant Taq DNA polymerase comprises at least one substitution at residue position 783 or 784 of unmodified Taq DNA polymerase.

[0024] In another embodiment, a mutant thermostable DNA polymerase is provided that has increased template discrimination activity compared to an unmodified thermostable DNA polymerase. The amino acid sequence of the mutant thermostable DNA polymerase comprises at least one substitution at a residue position orthologous to positions 783 or 784 of the unmodified Taq DNA polymerase.

[0025] In another embodiment, a mutant DNA polymerase having increased template discrimination activity compared to a corresponding unmodified DNA polymerase is provided, the mutant DNA polymerase comprising a thermostable polymerase, wherein the amino acid sequence of the mutant DNA polymerase peptide comprises at least one substitution at a residue position orthologous to position 783 or 784 of unmodified Taq DNA polymerase, and wherein the mutant DNA polymerase is selected from the group of species consisting of E. coli, Eubacterium siraeum, Clostridium leptum, Enterococcus, Facklamia hominis, Bacillus anthracis, and Bacillus cereus ATCC 10987.

[0026] In another embodiment, a mutant non-VH-related DNA polymerase is provided that has increased template discrimination activity compared to its unmodified non-VH-related DNA polymerase counterpart, the mutant non-VH-related DNA polymerase comprising a thermostable polymerase, the amino acid sequence of the mutant non-VH-related DNA polymerase comprising at least one substitution at a residue position orthologous to residue positions 783 and / or 784 of the unmodified Taq DNA polymerase.

[0027] In another embodiment, a recombinant nucleic acid encoding any of the mutant DNA polymerases described above is provided.

[0028] In another embodiment, a method for performing primer extension is provided, the method comprising contacting a mutant DNA polymerase as described above with a primer, a polynucleotide template and a nucleoside triphosphate under conditions suitable for the primer extension method, thereby generating an extended primer.

[0029] In another embodiment, a kit for generating extended primers is provided that includes at least one container providing a mutant DNA polymerase as described above.

[0030] In another embodiment, a reaction mixture is provided that includes a mutant DNA polymerase as described above, at least one primer, a polynucleotide template and nucleoside triphosphates.

[0031] In another embodiment, a method for performing rhPCR is provided, comprising the step of performing primer extension with a mutant DNA polymerase as described above.

[0032] In another embodiment, a mutant Taq DNA polymerase is provided that has increased template discrimination activity compared to the unmodified Taq DNA polymerase. The amino acid sequence of the mutant Taq DNA polymerase comprises one of the following selected substitutions: (1) A661E;I665W;F667L [SEQ ID NO:87]; (2) V783F [SEQ ID NO:83]; (3) H784Q [SEQ ID NO:85]; (4) V783L;H784Q [SEQ ID NO:89]; (5) H784A [SEQ ID NO:147]; (6) H784S [SEQ ID NO:149]; (7) H784I [SEQ ID NO:155]; (8) H784T [SEQ ID NO:151], (9) H784V [SEQ ID NO:153]; (10) H784M [SEQ ID NO:157]; (11) H784F [SEQ ID NO:159]; or (12) H784Y [SEQ ID NO:161].

[0033] In another embodiment, there is provided a mutant Taq DNA polymerase that has a deleted 5' exonuclease domain (KlenTaq) and contains additional mutations, and has increased template discrimination activity compared with unmodified Taq DNA polymerase.The amino acid sequence of mutant Taq DNA polymerase comprises one of the following selected substitutions: (1) A661E; I665W; F667L [SEQ ID NO: 170]; (2) V783F [SEQ ID NO: 172]; (3) H784Q [SEQ ID NO: 174]; (4) V783L; H784Q [SEQ ID NO: 176]; (5) H784S [SEQ ID NO: 178]; or (6) H784Y [SEQ ID NO: 180]. [Brief description of the drawings]

[0034] [Figure 1] Figure 1 shows a model of the active site constructed from the known Taq DNA polymerase PDB ID 2KTQ crystal structure. The polymerase backbone is shown using ribbons. The "C2" label indicates the 2' carbon atom of the terminal nucleotide of the primer. A dNTP is bound in a pocket on the primer. [Figure 2A]Figure 1 shows gel images showing purified proteins for Taq DNA polymerase mutants and wild-type Taq DNA polymerase. Legend: Aliquots of purified recombinant proteins were separated by polyacrylamide gel electrophoresis (PAGE) and stained with Coomassie brilliant blue. Marker lanes (M) are indicated and show protein size markers identified in kilodaltons (kDa). [Figure 2B] Figure 2 shows gel images showing purified proteins for Taq DNA polymerase mutants and wild-type Taq DNA polymerase, legend as in Figure 2A. [Figure 2C] Figure 2 shows gel images showing purified proteins for Taq DNA polymerase mutants and wild-type Taq DNA polymerase, legend as in Figure 2A. [Figure 2D] Figure 2 shows gel images showing purified proteins for Taq DNA polymerase mutants and wild-type Taq DNA polymerase, legend as in Figure 2A. [Figure 3A] Figure 1 shows a graphical representation of allele-specific PCR (AS-PCR) data from Tables 10 and 31 for wild-type OptiTaq (subpanel (i)), mutant ID2 (subpanel (ii)) and mutant ID3 (subpanel (iii)). Legend: Shows the average ΔCq values ​​± standard deviation (error bars) obtained from AS-PCR reactions. (ΔCq=Cqmismatch-Cqmatch). Comparing the mismatch discrimination of wild-type OptiTaq and mutant Taq DNA polymerases. All possible pairwise mismatched base combinations are included. The identity of the base at the SNP site in the target nucleic acid is indicated on the x-axis (A, G, C, T), along with the 3'-DNA residues of the employed AS-PCR reverse primer (dA, dG, dC, dT). [Figure 3B]Figure 3 shows a graphical representation of allele-specific PCR (AS-PCR) data from Tables 10 and 31 for wild type OptiTaq (subpanel (i)), mutant ID10 (subpanel (ii)) and mutant ID18 (subpanel (iii)). Legend as in Figure 3A. [Figure 3C] Figure 3 shows a graphical representation of allele-specific PCR (AS-PCR) data from Tables 10 and 31 for wild-type OptiTaq (subpanel (i)), mutant ID3 (subpanel (ii)) and mutant ID20 (subpanel (iii)). Legend as in Figure 3A. [Figure 3D] Figure 3 shows a graphical representation of allele-specific PCR (AS-PCR) data from Tables 10 and 31 for wild-type OptiTaq (subpanel (i)), mutant ID21 (subpanel (ii)) and mutant ID22 (subpanel (iii)). Legend as in Figure 3A. [Figure 3E] Figure 3 shows a graphical representation of allele-specific PCR (AS-PCR) data from Tables 10 and 31 for wild-type OptiTaq (subpanel (i)), mutant ID24 (subpanel (ii)) and mutant ID26 (subpanel (iii)). Legend as in Figure 3A. [Figure 3F] Figure 3 shows a graphical representation of allele-specific PCR (AS-PCR) data from Tables 10 and 31 for wild-type OptiTaq (subpanel (i)), mutant ID27 (subpanel (ii)) and mutant ID29 (subpanel (iii)). Legend as in Figure 3A. [Figure 3G] Figure 3 shows a graphical representation of allele-specific PCR (AS-PCR) data from Tables 10 and 31 for wild-type OptiTaq (subpanel (i)) and mutant ID30 (subpanel (ii)). Legend as in Figure 3A. [Figure 4]Figure 13 shows a graphical representation of qPCR results using primers terminating in a 3'-RNA residue and a 3'-DNA residue for wild type OptiTaq and ΔCq values ​​(Table 13) obtained from comparison with four mutant Taq DNA polymerases, where ΔCq=Cq3'-RNA-Cq3'-DNA; rA compared to dA, rC compared to dC, rG compared to dG, and rU compared to dT. The identity of each DNA polymerase studied is indicated on the X-axis. [Figure 5A] Figure 2 shows a graphical representation of ΔCq values ​​(Tables 20 and 34) obtained from a comparison of mismatch discrimination between wild type OptiTaq and mutant ID2, mutant ID3, mutant ID10 and mutant ID18 Taq DNA polymerases using Gen1 RDDDDx blocked cleavable primers in a quantitative rhPCR assay to detect a human genomic DNA SNP in the SMAD7 gene (NM_005904, C / T SNP, rs4939827). ΔCq=[Cqmismatch-Cqmatch]. Legend: The identity of each DNA polymerase studied is indicated on the x-axis. The RDDDDx blocked cleavable primers contained either rC or rU residues as the cleavable base, specific for the "C" or "T" allele, as indicated. [Figure 5B] FIG. 5B shows a graphical representation of ΔCq values ​​(Tables 20 and 34) obtained from a comparison of mismatch discrimination between wild type OptiTaq and mutant ID3, mutant ID20, mutant ID21, mutant ID22 and mutant ID24 Taq DNA polymerases using Gen1 RDDDDx blocked-cleavable primers in a quantitative rhPCR assay to detect a human genomic DNA SNP in the SMAD7 gene (NM_005904, C / T SNP, rs4939827). ΔCq=[Cqmismatch-Cqmatch]. Legend as in FIG. 5A. [Figure 5C]FIG. 5B shows a graphical representation of ΔCq values ​​(Tables 20 and 34) obtained from a comparison of mismatch discrimination between wild type OptiTaq and mutant ID3, mutant ID26, mutant ID27, mutant ID29 and mutant ID30 Taq DNA polymerases using Gen1 RDDDDx blocked-cleavable primers in a quantitative rhPCR assay to detect a human genomic DNA SNP in the SMAD7 gene (NM_005904, C / T SNP, rs4939827). ΔCq=[Cqmismatch-Cqmatch]. Legend as in FIG. 5A. [Figure 6A] Figure 2 shows a graphical representation of ΔCq values ​​(Tables 21 and 35) obtained from a comparison of mismatch discrimination between wild type OptiTaq and mutant ID2, mutant ID3, mutant ID10 and mutant ID18 Taq DNA polymerases using Gen2 RDxxD blocked cleavable primers in a quantitative rhPCR assay to detect a human genomic DNA SNP in the SMAD7 gene (NM_005904, C / T SNP, rs4939827). ΔCq=[Cqmismatch-Cqmatch]. Legend: The identity of each DNA polymerase studied is indicated on the X-axis. The RDxxD blocked cleavable primers contained either rC or rU residues as the cleavable base, specific for "C" or "T" as indicated. [Figure 6B] FIG. 6B shows a graphical representation of ΔCq values ​​(Tables 21 and 35) obtained from a comparison of mismatch discrimination between wild-type OptiTaq and mutant ID3, mutant ID20, mutant ID21, mutant ID22 and mutant ID24 Taq DNA polymerases using Gen2 RDxxD blocked-cleavable primers in a quantitative rhPCR assay to detect a human genomic DNA SNP in the SMAD7 gene (NM_005904, C / T SNP, rs4939827). ΔCq=[Cqmismatch-Cqmatch]. Legend as in FIG. 6A. [Figure 6C]FIG. 6B shows a graphical representation of ΔCq values ​​(Tables 21 and 35) obtained from a comparison of mismatch discrimination between wild-type OptiTaq and mutant ID3, mutant ID26, mutant ID27, mutant ID29 and mutant ID30 Taq DNA polymerases using Gen2 RDxxD blocked-cleavable primers in a quantitative rhPCR assay to detect a human genomic DNA SNP in the SMAD7 gene (NM_005904, C / T SNP, rs4939827). ΔCq=[Cqmismatch-Cqmatch]. Legend as in FIG. 6A. [Figure 7A] Figure 1 shows a graphical representation of allele-specific PCR (AS-PCR) data from Tables 10 and 31 for OptiTaq KlenTaq (mutant ID37) (subpanel (i)), mutant ID38 (subpanel (ii)) and mutant ID39 (subpanel (iii)). Legend: Shows the average ΔCq values ​​± standard deviation (error bars) obtained from AS-PCR reactions. (ΔCq=Cqmismatch-Cqmatch). Comparing the mismatch discrimination of wild-type OptiTaq and the four mutant Taq DNA polymerases. All possible pairwise mismatched base combinations are included. The identity of the base at the SNP site in the target nucleic acid is indicated on the x-axis (A, G, C, T), along with the 3'-DNA residues of the employed AS-PCR reverse primer (dA, dG, dC, dT). [Figure 7B] FIG. 7 shows a graphical representation of allele-specific PCR (AS-PCR) data from Tables 10 and 31 for OptiTaq KlenTaq (mutant ID37) (subpanel (i)), mutant ID40 (subpanel (ii)) and mutant ID41 (subpanel (iii)). Legend as in FIG. 7A. [Figure 7C] FIG. 7 shows a graphical representation of allele-specific PCR (AS-PCR) data from Tables 10 and 31 for OptiTaq KlenTaq (mutant ID37) (subpanel (i)), mutant ID42 (subpanel (ii)) and mutant ID43 (subpanel (iii)). Legend as in FIG. 7A. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0035] The present invention provides novel thermostable DNA polymerases, including embodiments derived from Thermus aquaticus (Taq) DNA polymerase. These polymerases represent an improvement over existing methods for nucleic acid amplification, genotyping, and detection of low frequency alleles. Also provided are novel assay formats that include the use of these novel thermostable DNA polymerases.

[0036] definition To aid in the understanding of this invention, several terms are defined below.

[0037] The terms used in this specification are intended as "open" terms (e.g., the term "including" should be intended as "including but not limited to", the term "having" should be intended as "having at least", the term "including" should be intended as "including but not limited to", etc.).

[0038] The articles "a" and "an" refer to one or to more than one (e.g., to at least one) of the grammatical object of the article.

[0039] The terms "about" and "approximately" are generally intended to mean a tolerance of error for the quantity measured given the nature or precision of the measurement. Example tolerances are within 20-25 percent (%), typically within 10%, and more typically within 5% of a given value or range of values.

[0040] Moreover, in instances where a conventional expression similar to "at least one of A, B, and C, etc." is used, such syntax is typically intended in the sense that one of ordinary skill in the art would understand the conventional expression (e.g., "a system having at least one of A, B, and C" includes, but is not limited to, systems having only A, only B, only C, A and B together, A and C together, B and C together, and / or A, B, and C together, etc.). Those of ordinary skill in the art will further appreciate that virtually any disjunctive word and / or phrase presenting two or more alternative terms should be understood to contemplate the possibility of including one of the terms, either of the terms, or both of the terms in the specification or drawings. For example, the phrase "A or B" is understood to include the possibilities of "A" or "B" or "A and B."

[0041] All phrases such as "from," "to," "up to," "at least," "more than," "less than," and the like, refer to ranges that include the recited numbers and that can be subsequently divided into subranges.

[0042] Ranges include each individual member. Thus, for example, a group having 1-3 members means groups having 1, 2 or 3 members. Similarly, a group having 6 members means groups having 1, 2, 3, 4 or 6 members, etc.

[0043] The modal verb "may" refers to a preferred use or selection of one or more alternatives, or a selection among several described embodiments or features contained within the same. When no alternatives or selections are disclosed with respect to a particular embodiment or feature contained within the same, the modal verb "may" refers to a positive action regarding how to make or use an aspect of the described embodiment or feature contained within the same, or a definitive decision to use a specific technique with respect to the described embodiment or feature contained within the same. In this latter context, the modal verb "may" has the same meaning and connotation as the modal verb "can."

[0044] The terms "normal" or "natural" when referring to a nucleobase, nucleoside triphosphate, or nucleotide, mean those that occur naturally in the described polynucleotide (i.e., for DNA, these are dATP, dGTP, dCTP, and dTTP). In addition, dITP and 7-deaza-dGTP are frequently utilized in place of dGTP, and 7-deaza-dATP can be utilized in place of dATP in in vitro DNA synthesis reactions, such as sequencing. Collectively, these can be referred to as dNTPs.

[0045] When referring to a nucleic acid base, nucleoside or nucleotide, the term "unconventional" or "modified" includes modifications, derivatives or analogs of the normal base, nucleoside or nucleotide that naturally occurs in a particular polynucleotide. Certain unconventional nucleotides are modified at the 2' position of the ribose sugar compared to the normal dNTPs. Thus, with respect to RNA, the naturally occurring nucleotides are ribonucleotides (i.e., ATP, GTP, CTP, UTP, collectively rNTPs), but as described herein, these nucleotides have a hydroxyl group at the 2' position of the sugar, and compared to the absence of dNTPs, as used herein, ribonucleotides are unconventional nucleotides as substrates for DNA polymerases. As used herein, unconventional nucleotides include, but are not limited to, compounds used as terminators for nucleic acid sequencing. Exemplary terminator compounds include, but are not limited to, compounds that have a 2',3' dideoxy structure and are referred to as dideoxynucleoside triphosphates. The dideoxynucleoside triphosphates ddATP, ddTTP, ddCTP and ddGTP are collectively referred to as ddNTPs.

[0046] The term "nucleotide," in addition to referring to naturally occurring ribonucleotide or deoxyribonucleotide monomers, is understood herein to refer to related structural variants thereof, and includes derivatives and analogs that are functionally equivalent for the particular context in which the nucleotide is used (e.g., hybridization to a complementary base), unless the context clearly dictates otherwise.

[0047] The terms "nucleic acid" and "oligonucleotide" as used herein refer to polydeoxyribonucleotides (including 2-deoxy-D-ribose), polyribonucleotides (including D-ribose), and any other type of polynucleotide that is an N-glycoside of a purine or pyrimidine base. No distinction in length is intended between the terms "nucleic acid", "oligonucleotide" and "polynucleotide". These terms are used interchangeably. These terms refer only to the primary structure of the molecule. Thus, these terms include double-stranded and single-stranded DNA, as well as double-stranded and single-stranded RNA. For use in the present invention, oligonucleotides can also include nucleotide analogs modified in the base, sugar or phosphate backbone, as well as non-purine or non-pyrimidine nucleotide analogs.

[0048] Oligonucleotides can be prepared by any suitable method, including direct chemical synthesis by methods such as the phosphotriester method of Narang et al., 1979, Meth. Enzymol. 68:90-99; the phosphodiester method of Brown et al., 1979, Meth. Enzymol. 68:109-151; the diethyl phosphoramidite method of Beaucage et al., 1981, Tetrahedron Lett., 22:1859-1862; and the solid support method of U.S. Patent No. 4,458,066, each of which is incorporated herein by reference. A review of methods for synthesizing oligonucleotide and modified nucleotide conjugates is given in Goodchild, 1990, Bioconjugate Chemistry 1(3):165-187, which is incorporated herein by reference.

[0049] The term "primer" as used herein refers to an oligonucleotide that can act as a starting point for DNA synthesis under appropriate conditions. Such conditions include conditions that induce synthesis of primer extension products complementary to a nucleic acid strand in the presence of four different nucleoside triphosphates and an agent for extension (e.g., DNA polymerase or reverse transcriptase) in a suitable buffer at an appropriate temperature. Primer extension can also be performed in the absence of one or more nucleotide triphosphates, in which case extension products of limited length are produced. As used herein, the term "primer" is intended to encompass oligonucleotides used in ligation-mediated reactions in which one oligonucleotide is "extended" by ligation to a second oligonucleotide that hybridizes at an adjacent position. Thus, the term "primer extension" as used herein refers to both the polymerization of individual nucleoside triphosphates using a primer as a starting point for DNA synthesis, and the ligation of two oligonucleotides to form an extension product.

[0050] The primer is preferably a single-stranded DNA. The suitable length of the primer depends on the intended use of the primer, but typically ranges from 6 to 50 nucleotides, preferably from 15 to 35 nucleotides. Short primer molecules generally require lower temperatures to form sufficiently stable hybrid complexes with the template. The primer does not need to reflect the exact sequence of the template nucleic acid, but must be sufficiently complementary to hybridize with the template. The design of suitable primers for amplifying the desired target sequence is well known in the art and described in the literature cited herein.

[0051] Primers may incorporate additional features that allow the primer to be detected or immobilized, but do not change the basic properties of the primer, which acts as a starting point for DNA synthesis.For example, primers may contain additional nucleic acid sequences at the 5' end that do not hybridize to target nucleic acid, but facilitate cloning or detection of amplification products.The region of the primer that is sufficiently complementary to the template to hybridize is referred to herein as hybridizing region.Primers may incorporate modified residues other than DNA, as long as the modification does not interfere with priming or template function.

[0052] The phrase "3'-nucleotide discrimination" refers to the property of a DNA polymerase to catalyze a primer extension reaction with greater specificity and less efficiency for deoxyribonucleotides when the 3'-terminal nucleotide of the primer is chemically modified. For example, a mutated Taq DNA polymerase that displays 3'-nucleotide discrimination shows selectivity for deoxyribonucleotide primers and reduced catalytic activity when the primer is modified, for example, with a ribonucleotide.

[0053] The term "3'-mismatch discrimination" refers to the property of a DNA polymerase to distinguish a perfectly complementary sequence from a mismatch-containing (near-complementary) sequence, where the nucleic acid to be extended (e.g., a primer or other oligonucleotide) has a mismatch at the 3' end of the nucleic acid compared to the template to which the nucleic acid hybridizes. In some embodiments, the nucleic acid to be extended contains a mismatch at the 3' end relative to the perfectly complementary sequence.

[0054] The term "low frequency allele discrimination" refers to the property of a DNA polymerase to preferentially replicate a first nucleic acid in a nucleic acid population comprising a plurality of second nucleic acids, where the first nucleic acid is under-represented in the nucleic acid population relative to the plurality of second nucleic acids. Typically, the first nucleic acid may be under-represented in a nucleic acid population containing a plurality of second nucleic acids at a ratio of the first nucleic acid to the second nucleic acid ranging from about 1:10 to about 1:1,000,000, including 1:100, 1:1,000 and 1:100,000, among other ratios. Typically, but not exclusively, polymerases with low frequency allele discrimination can be used to detect SNP differences between a first nucleic acid and a second nucleic acid, as further detailed herein.

[0055] The phrase "template discrimination activity" refers to a DNA polymerase that has at least one of 3'-nucleotide discrimination, 3'-mismatch discrimination, low frequency allele discrimination, and combinations thereof.

[0056] The phrase "enhanced discrimination activity" refers to a DNA polymerase that has at least one of 3'-nucleotide discrimination, 3'-mismatch discrimination, and low-frequency allele discrimination, or a combination thereof, where the DNA polymerase exhibits higher activity than a reference DNA polymerase.For example, a DNA polymerase mutant with "enhanced template discrimination activity" exhibits at least one of 3'-nucleotide discrimination, 3'-mismatch discrimination, low-frequency allele discrimination, and a combination thereof that is higher than the corresponding activity of the naturally occurring wild-type DNA polymerase from which the DNA polymerase mutant is derived.

[0057] "Template discrimination activity assay" refers to an assay for evaluating the ability of a polymerase to discriminate between two templates that differ in one or more variables. Assays designed to reveal 3'-nucleotide discrimination, 3'-mismatch discrimination, or low frequency allele discrimination are examples of template discrimination activity assays.

[0058] The term "quantitation cycle value", written as Cq, refers to the amplification cycle number at which a positive signal is first detected.

[0059] The term "discrimination quantification cycle value" is described as ΔCq and refers to the calculated difference between a first reference state and a second reference state, where both the first and second reference states differ in only one variable. For example, the first and second reference states can refer to the same polymerase reaction that differs in polymerase, such as a wild-type polymerase and a polymerase mutant, differs in primer template nucleotide sequence, such as a mismatched primer template and a matched primer template, or differs in primer template 3'-nucleotide ribose structure, such as a primer template containing a 3'-deoxyribose moiety and a primer template containing a 3'-ribose moiety.

[0060] The term "differential discrimination quantification cycle value" is written as ΔΔCq and refers to the calculated difference between the first discrimination quantification cycle value and the second discrimination quantification cycle value for polymerase reactions that differ in two variables. In the context of the present disclosure, the ΔΔCq value is a measure of the improvement that a given polymerase mutant exhibits compared to a wild-type polymerase in a template discrimination activity assay. The preferred ΔΔCq value depends on the nature of the assay, but in general, the preferred ΔΔCq value is at least 1.0, and typically greater than 1.0.

[0061] The terms "target," "target sequence," "target region," and "target nucleic acid," as used herein, are synonymous and refer to a region or sequence of a nucleic acid that is to be amplified, sequenced, or detected.

[0062] The term "template" refers to a nucleic acid that includes at least one single-stranded region. The term "template" when used to modify "substrate" refers to a nucleic acid that is used in a hybridization reaction to anneal with a primer and / or an extension reaction with a polymerase.

[0063] The term "hybridization" as used herein refers to the formation of a duplex structure by two single-stranded nucleic acids due to complementary base pairing. Hybridization can occur between completely complementary nucleic acid strands or between "substantially complementary" nucleic acid strands that contain minor regions of mismatch. Conditions under which completely complementary nucleic acid strands hybridize are highly favorable are referred to as "stringent hybridization conditions" or "sequence-specific hybridization conditions". Stable duplexes of substantially complementary sequences can be achieved under less stringent hybridization conditions; the degree of mismatch allowed can be controlled by appropriately adjusting hybridization conditions. Those skilled in the art of nucleic acid technology can empirically determine duplex stability following guidelines provided by the art (see, e.g., Sambrook et al., 1989, Molecular Cloning--A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY; Wetmur, 1991, Critical Review in Biochem. and Mol. Biol. 26(3 / 4):227-259; and Owczarzy et al., 2008, Biochemistry, 47:5336-5353, all of which are incorporated herein by reference), taking into account several variables including, for example, the length and base pair composition of the oligonucleotide, ionic strength, and the frequency of mismatched base pairs.

[0064] The term "amplification reaction" refers to any chemical reaction, including an enzymatic reaction, that results in more copies of a template nucleic acid sequence or results in transcription of a template nucleic acid. Amplification reactions include reverse transcription, polymerase chain reaction (PCR), including real-time PCR (see U.S. Pat. Nos. 4,683,195 and 4,683,202; see PCR Protocols: A Guide to Methods and Applications (Innis et al., eds., 1990)), and ligase chain reaction (LCR) (see Barany et al., U.S. Pat. No. 5,494,810). Exemplary "amplification reaction conditions" or "amplification conditions" typically include either a two-step or three-step cycle. A two-step cycle includes a high-temperature denaturation step, followed by a hybridization / extension (or ligation) step. A three-step cycle includes a denaturation step, followed by a hybridization step, followed by a separate extension or ligation step.

[0065] "Amino acid" refers to any monomeric unit that can be incorporated into a peptide, polypeptide or protein. As used herein, the term "amino acid" includes the following 20 naturally occurring or genetically encoded alpha-amino acids: alanine (Ala or A), arginine (Arg or R), asparagine (Asn or N), aspartic acid (Asp or D), cysteine ​​(Cys or C), glutamine (Gln or Q), glutamic acid (Glu or E), glycine (Gly or G), histidine (His or H), isoleucine (Ile or I), leucine (Leu or L), lysine (Lys or K), methionine (Met or M), phenylalanine (Phe or F), proline (Pro or P), serine (Ser or S), threonine (Thr or T), tryptophan (Trp or W), tyrosine (Tyr or Y) and valine (Val or V). When the "X" residues are not defined, they are defined as "any amino acid." The structures of these 20 naturally occurring amino acids are described, for example, in Stryer et al., Biochemistry, 5, incorporated by reference. thed., Freeman and Company (2002). Additional amino acids such as selenocysteine ​​and pyrrolidine can also be genetically encoded (Stadtman, (1996), "Selenocysteine", Annu Rev Biochem., 65:83-100, and Ibba et al., (2002), "Genetic code: introducing pyrrolidine", Curr Biol., 12(13):R464-R466, both of which are incorporated by reference). The term "amino acid" also includes unnatural amino acids, modified amino acids (e.g., having modified side chains and / or backbones), and amino acid analogs. See, e.g., Zhang et al., (2004), "Selective incorporation of 5-hydroxytryptophan into proteins in mammalian cells," Proc. Natl. Acad. Sci. USA 101(24):8882-8887; Anderson et al., (2004), "An expanded genetic code with a functional quadruplet codon," Proc. Natl. Acad. Sci. USA, 101(20):7566-7571; Ikeda et al., (2003), "Synthesis of a novel histidine analogue and its efficient incorporation into a protein in vivo," Protein Eng. Des. Sel., 16(9):699-706; and Chin et al., (2003), "An Expanded Eukaryotic Genetic Code', Science, 301(5635):964-967, James et al., (2001), 'Kinetic characterization of ribonuclease S mutants containing photoisomerizable phenylazophenylalanine residues', Protein Eng.Des.Sel., 14(12):983-991, Kohrer et al. (2001), “Import of amber and ochre suppressor tRNAs into mammalian cells: A general approach to site-specific insertion of amino acid analogues into Bacher et al. (2001), “Selection and Characterization of Escherichia coli Variants Capable of Growth on an Otherwise Toxic Tryptophan Hamano-Takaku et al. (2000), “A Mutant Escherichia coli Tyrosyl-tRNA Synthetase Utilizes the Unnatural Amino Acid Azatyrosine More Efficiently than See, for example, Budisa et al., (2001), "Proteins with {beta}-(thienopyrrolyl)alanines as alternative chromophores and soluble active amino acids," Protein Sci., 10(7):1281-1292.

[0066] The term "residue" is synonymous with, and interchangeable with, "amino acid" or "nucleotide," depending on the context.

[0067] As used herein, "polymerase" refers to an enzyme that catalyzes the polymerization of nucleotides. Generally, the enzyme initiates synthesis at the 3' end of a primer annealed to a nucleic acid template sequence. "DNA polymerase" catalyzes the polymerization of deoxyribonucleotides.Known DNA polymerases include, for example, Pyrococcus furiosus (Pfu) DNA polymerase (Lundberg et al., 1991, Gene, 108:1), E. coli DNA polymerase (Lecomte and Doubleday, 1983, Nucleic Acids Res., 11:7505), T7 DNA polymerase (Nordstrom et al., 1981, J. Biol. Chem., 256:3112), Thermus thermophilus (Tth) DNA polymerase (Myers and Gelfand, 1991, Biochemistry, 30:7661), Bacillus stearothermophilus DNA polymerase (Stenesh and McGowan, 1977, Biochim Biophys Acta 475:32), Thermococcus litoralis (Tli) DNA polymerase (also called Vent DNA polymerase, Cariello et al., 1991, Nucleic Acids Res., 19:4193), Thermotoga maritima (Tma) DNA polymerase (Diaz and Sabino, 1998, Braz, J. Med. Res., 31:1239), Thermus aquaticus (Taq) DNA polymerase (Chien et al., 1976, J. Bacteoriol., 127:1550), Pyrococcus kodakaraensis KOD DNA polymerase (Takagi et al., 1997, Appl. Environ. Microbiol., 63:4504), JDF-3 DNA polymerase (International Publication No. WO0132887), and Pyrococcus sp. GB-D (PGB-D) DNA polymerase (Juncosa-Ginesta et al., 1994, Biotechniques, 16:820). The polymerase activity of any of the above enzymes can be determined by means well known in the art.

[0068] The term "thermostable polymerase" refers to an enzyme that is heat stable, thermotolerant, retains sufficient activity to accomplish a subsequent polynucleotide extension reaction, and is not irreversibly denatured (inactivated) when exposed to high temperatures for the time required to accomplish denaturation of double-stranded nucleic acids. Heating conditions required for nucleic acid denaturation are well known in the art and are exemplified, for example, in U.S. Patent Nos. 4,683,202, 4,683,195, and 4,965,188, which are incorporated herein by reference. As used herein, a thermostable polymerase is suitable for use in a temperature cycling reaction, such as the polymerase chain reaction ("PCR"). For purposes herein, irreversible denaturation refers to a permanent and complete loss of enzymatic activity. With respect to a thermostable polymerase, enzymatic activity refers to the catalysis of combining nucleotides in the proper manner to form polynucleotide extension products complementary to a template nucleic acid strand. Thermostable DNA polymerases from thermophilic bacteria include, for example, DNA polymerases from Thermus aquaticus, among others.

[0069] The term "thermophilic" refers to an enzyme that maintains catalytic properties at temperatures typically used for the reverse transcription or annealing / extension steps in RT-PCR and / or PCR reactions (i.e., 45-80°C). Thermostable enzymes are those that are not irreversibly inactivated and denatured when exposed to the high temperatures required for nucleic acid denaturation. Thermophilic enzymes may or may not be thermostable. Thermophilic DNA polymerases may be DNA- or RNA-dependent from thermophilic or mesophilic species, including, but not limited to, Escherichia coli, Moloney murine leukemia virus, and avian myeloblastosis virus.

[0070] As used herein, a primer is "specific" for a target sequence if, when used in an amplification reaction under sufficiently stringent conditions, the primer hybridizes primarily to the target nucleic acid. Typically, a primer is specific for a target sequence if the stability of the primer-target duplex is greater than the stability of the duplex formed between the primer and any other sequence found in the sample. Those skilled in the art will recognize that various factors, such as salt conditions and the base composition and mismatch position of the primer, affect the specificity of the primer, and routine experimental confirmation of primer specificity is required in many cases. Hybridization conditions can be selected that allow the primer to form a stable duplex only with the target sequence. Thus, the use of target-specific primers under appropriately stringent amplification conditions allows selective amplification of target sequences that contain the target primer binding site.

[0071] The term "non-specific amplification" as used herein refers to the amplification of nucleic acid sequences other than target sequences, which occurs from primers hybridizing to sequences other than target sequences and then acting as substrates for primer extension.The hybridization of primers to non-target sequences is called "non-specific hybridization" and tends to occur especially during low temperature, reduced stringency, pre-amplification conditions, or in the case of single nucleotide polymorphisms (SNPs), in the situation where mutant alleles exist in samples with sequences closely related to true targets.

[0072] The term "primer dimer" as used herein refers to template-independent non-specific amplification product that is believed to result from primer extension in which another primer serves as a template.Primer dimers often appear to be concatamers of two primers, i.e. dimers, but concatamers of more than two primers can also occur.The term "primer dimer" is used herein to comprehensively encompass template-independent non-specific amplification products.

[0073] The term "reaction mixture" as used herein refers to a solution containing the reagents required to perform a given reaction. An "amplification reaction mixture", which refers to a solution containing the reagents required to perform an amplification reaction, typically contains oligonucleotide primers and a DNA polymerase or ligase in a suitable buffer. A "PCR reaction mixture" typically contains oligonucleotide primers, a DNA polymerase (most typically a thermostable DNA polymerase), dNPT and a divalent metal cation in a suitable buffer. A reaction mixture is called complete if it contains all the reagents required to enable the reaction, and incomplete if it contains only a portion of the required reagents. It will be understood by those skilled in the art that reaction components are usually stored as separate solutions, each containing a portion of the total components, for reasons of convenience, storage stability, or allowing application-dependent adjustment of component concentrations, and that reaction components are combined prior to reaction to make a complete reaction mixture. Furthermore, it will be understood by those skilled in the art that reaction components are packaged separately for commercialization, and that useful commercial kits may contain any portion of the reaction components, including the blocked primers of the present invention.

[0074] The term "non-activated" or "inactivated" as used herein refers to a primer or other oligonucleotide that cannot participate in a primer extension or ligation reaction because either DNA polymerase or DNA ligase cannot interact with the oligonucleotide for their intended purpose. In some embodiments, when the oligonucleotide is a primer, the non-activated state occurs because the primer is blocked at or near the 3' end to prevent primer extension. When a specific group is attached to or near the 3' end of the primer, DNA polymerase cannot bind to the primer and extension cannot occur. However, a non-activated primer can hybridize to a substantially complementary nucleotide sequence.

[0075] The term "activated" as used herein refers to a primer or other oligonucleotide that can participate in a reaction with DNA polymerase or DNA ligase. A primer or other oligonucleotide becomes activated after hybridizing to a substantially complementary nucleic acid sequence and is cleaved to generate a functional 3' or 5' end that can interact with DNA polymerase or DNA ligase. For example, when an oligonucleotide is a primer and the primer is hybridized to a template, the 3'-blocking group can be removed from the primer by a cleavage enzyme, for example, so that a DNA polymerase can bind to the 3' end of the primer and promote primer extension.

[0076] The term "cleavage domain" or "cleaving domain" as used herein are synonymous and refer to the region located between the 5' and 3' ends of a primer or other oligonucleotide that is recognized by a cleavage compound, such as a cleavage enzyme, that cleaves the primer or other oligonucleotide. For the purposes of the present invention, the cleavage domain is designed so that it is only cleaved when the primer or other oligonucleotide is hybridized to a complementary nucleic acid sequence, but not when it is single-stranded. The cleavage domain or the sequence adjacent to the cleavage domain may include a moiety that a) prevents or inhibits the extension or ligation of the primer or other oligonucleotide by a polymerase or ligase, b) increases discrimination to detect mutant alleles, or c) suppresses undesired cleavage reactions. One or more such moieties may be included in the cleavage domain or the sequence adjacent to the cleavage domain.

[0077] The term "RNase H cleavage domain," as used herein, is a type of cleavage domain that contains one or more ribonucleic acid residues or alternative analogs that provide a substrate for RNase H. The RNase H cleavage domain can be located anywhere within the primer or oligonucleotide, and is preferably located at or near the 3' or 5' end of the molecule.

[0078] An "RNase H1 cleavage domain" generally contains at least three consecutive RNA residues. An "RNase H2 cleavage domain" may contain a single RNA residue, a sequence of consecutively linked RNA residues, or RNA residues separated by DNA residues or other chemical groups. For example, an RNase H2 cleavage domain may contain, inter alia, a 2'-fluoronucleoside residue.

[0079] The term "cleavage compound" or "cleavage agent" as used herein refers to any compound that can recognize a cleavage domain in a primer or other oligonucleotide and selectively cleave the oligonucleotide based on the presence of the cleavage domain. The cleavage compounds utilized in the present invention selectively cleave the primer or other oligonucleotide containing the cleavage domain only when hybridized to a substantially complementary nucleic acid sequence, but do not cleave the primer or other oligonucleotide when single stranded. The cleavage compound cleaves the primer or other oligonucleotide within or adjacent to the cleavage domain. The term "adjacent" as used herein means that the cleavage compound cleaves the primer or other oligonucleotide at either the 5' or 3' end of the cleavage domain. The cleavage reaction preferred in the present invention produces a 5'-phosphate group and a 3'-OH group.

[0080] In a preferred embodiment, the cleavage compound is a "cleavage enzyme." A cleavage enzyme is capable of recognizing a cleavage domain when a primer or other oligonucleotide is hybridized to a substantially complementary nucleic acid sequence, but does not cleave the complementary nucleic acid sequence (i.e., produces a single-stranded break within the duplex). A cleavage enzyme also does not cleave a primer or other oligonucleotide containing a cleavage domain when it is single-stranded. Examples of cleavage enzymes are RNase H enzymes and other nicking enzymes.

[0081] The term "nicking" as used herein refers to cleaving only one strand of a double-stranded portion of a fully or partially double-stranded nucleic acid. The location where a nick is generated in a nucleic acid is referred to as the "nicking site" (NS). A "nicking agent" (NA) is an agent that generates a nick in a partially or fully double-stranded nucleic acid. A nicking agent can be an enzyme or any other compound or composition. In certain embodiments, a nicking agent can recognize a specific nucleotide sequence in a fully or partially double-stranded nucleic acid and cleave only one strand of a fully or partially double-stranded nucleic acid at a specific location (i.e., NS) relative to the location of the recognition sequence. Such nicking agents (referred to as "sequence-specific nicking agents") include, but are not limited to, nicking endonucleases (e.g., N.BstNB1).

[0082] Thus, a "nicking endonuclease" (NE), as used herein, refers to an endonuclease that recognizes a nucleotide sequence in a fully or partially double-stranded nucleic acid molecule and cleaves only one strand of the nucleic acid molecule at a specific location relative to the recognition sequence. In such cases, the entire sequence from the recognition site to the cleavage point constitutes the "cleavage domain."

[0083] The term "blocking group" as used herein refers to a chemical moiety that is attached to a primer or other oligonucleotide so that the amplification reaction does not occur. For example, primer extension and / or DNA ligation does not occur. When the blocking group is removed from the primer or other oligonucleotide, the oligonucleotide can participate in the assay for which it is designed (PCR, ligation, sequencing, etc.). Thus, a "blocking group" can be any chemical moiety that inhibits recognition by a polymerase or DNA ligase. The blocking group can be incorporated into the cleavage domain, but is generally located either 5' or 3' to the cleavage domain. The blocking group can be composed of more than one chemical moiety. In the present invention, the "blocking group" is typically removed after hybridization of the oligonucleotide to its target sequence.

[0084] The term "blocked cleavable primer" refers to a primer that is inactive or inactivated against priming of DNA synthesis from a polymerase due to the presence of a blocking group at or near the 3' end of the primer. A blocked cleavable primer can be converted to a competent primer by removing the blocking group at or near the 3' end of the primer with a cleavage compound or agent (e.g., a cleavage enzyme) resulting in an active or activated primer.

[0085] RDDDDx blocked cleavable primer (also known as a "generation 1" or "Gen 1" blocked cleavable primer) refers to a blocked cleavable primer having the sequence RDDDDx at its 3' end, where R is an RNA base, D is a DNA base, and x is a C3 spacer group.

[0086] RDxxD blocked cleavable primer (also known as a "generation 2" or "Gen 2" blocked cleavable primer) refers to a blocked cleavable primer having the sequence RDxxD at its 3' end, where R is an RNA base, D is a DNA base, and x is a C3 spacer group.

[0087] The term "fluorogenic probe" refers to either a) an oligonucleotide having a fluorophore and a quencher attached thereto, and optionally a minor groove binding moiety attached thereto, or b) a DNA binding reagent, such as SYBR™ Green dye.

[0088] The term "fluorescent label" or "fluorophore" refers to a compound having a maximum fluorescence emission between about 350 and 900 nm. A wide variety of fluorophores may be used, including but not limited to: 5-FAM (also referred to as 5-carboxyfluorescein; spiro(isobenzofuran-1(3H),9'-(9H)xanthene)-5-carboxylic acid, also referred to as 3',6'-dihydroxy-3-oxo-6-carboxyfluorescein); 5-hexachloro-fluorescein; ([4,7,2',4',5',7'-hexachlorofluorescein; 6-Hexachloro-fluorescein;([4,7,2',4',5',7'-Hexachloro-(3',6'-dipivaloylfluoresceinyl)-5-carboxylic acid]);5-Tetrachloro-fluorescein;([4,7,2',7'-Tetrachloro-(3',6'-dipivaloylfluoresceinyl)-5-carbox 6-Tetrachloro-fluorescein;([4,7,2',7'-Tetrachloro-(3',6'-dipivaloylfluoresceinyl)-6-carboxylic acid]);5-TAMRA (5-carboxytetramethylrhodamine);Xanthylium, 9-(2,4-dicarboxyphenyl)-3,6-bis(dimethylamino);6-TAMRA (6-carboxytetramethylrhodamine);9-(2,5-dicarboxyphenyl)-3,6-bis(dimethylamino);EDANS (5-((2-aminoethyl)amino)naphthalene-1-sulfonic acid);1,5-IAEDANS (5-((((2-iodoacetyl)amino)ethyl)amino)naphthalene-1-sulfonic acid);Cy5 (indodicarbocyanine-5);Cy3 (indo-dicarbocyanine-3);and BODIPY FL (2,6-dibromo-4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-propionic acid); Quasar®-670 dye (Biosearch Technologies); Cal Fluor® Orange dye (Biosearch Technologies); Rox dyes; Max dyes (Integrated DNA Technologies), as well as suitable derivatives thereof.

[0089] As used herein, the term "quencher" refers to a molecule or a portion of a compound that can reduce the emission from a fluorescent donor when it is bound to or in close proximity to the donor. Quenching can be achieved by any of several mechanisms, such as fluorescence resonance energy transfer, photoinduced electron transfer, paramagnetic promotion of intersystem crossing, Dexter exchange coupling, and exciton coupling, such as the formation of dark complexes. Fluorescence is "quenched" when the fluorescence emitted by a fluorophore is reduced by at least 10%, for example, 15%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, 98%, 99%, 99.9% or more, compared to the fluorescence in the absence of the quencher. Several commercially available quenchers are known in the art, including, but not limited to, DABCYL, Black Hole™ quenchers (BHQ-1, BHQ-2 and BHQ-3), Iowa Black® FQ and Iowa Black® RQ. These are so-called dark quenchers. They have no intrinsic fluorescence in the wavelength range of 300 to 900 nm, effectively eliminating the background problems seen with other quenchers that are intrinsically fluorescent, such as TAMRA.

[0090] The term "ligation" as used herein refers to the covalent joining of two polynucleotide ends. In various embodiments, ligation involves the covalent joining of the 3' end of a first polynucleotide (acceptor) with the 5' end of a second polynucleotide (donor). Ligation results in the formation of a phosphodiester bond between the polynucleotide ends. In various embodiments, ligation can be mediated by any enzyme, chemical, or process that results in the covalent joining of polynucleotide ends. In certain embodiments, ligation is mediated by a ligase enzyme.

[0091] "Ligase," as used herein, refers to an enzyme that can covalently link the 3' hydroxyl group of one polynucleotide to the 5' phosphate group of a second polynucleotide. Examples of ligases include E. coli DNA ligase, T4 DNA ligase, and the like.

[0092] Ligation reactions can be used in DNA amplification methods, for example in "ligase chain reaction" (LCR) (also referred to as "ligase amplification reaction" (LAR), see Barany, Proc. Natl. Acad. Sci., 88:189 (1991); and Wu and Wallace, Genomics 4:560 (1989), incorporated herein by reference). In LCR, four oligonucleotides are mixed, two adjacent oligonucleotides that hybridize uniquely to one strand of target DNA and a complementary set of adjacent oligonucleotides that hybridize to the opposite strand, and DNA ligase is added to the mixture. In the presence of the target sequence, DNA ligase covalently joins each of the sets of hybridized molecules. Importantly, in LCR, two oligonucleotides are ligated to each other only if they base-pair with a sequence that does not have a gap. Repeated cycles of denaturation, hybridization, and ligation result in the amplification of short segments of DNA. Mismatches at the junctions between adjacent oligonucleotides inhibit ligation. As with other oligonucleotide ligation assays, this property allows LCR to be used to discriminate between variant alleles, such as SNPs. LCR has also been used in conjunction with PCR to obtain improved detection of single base changes. See Segev, WO 9001069 (1990).

[0093] The term "unmodified form" is used herein in the context of Taq DNA polymerase to define a host cell specific codon-optimized Taq DNA polymerase gene that expresses Taq DNA polymerase in a host cell. The term "unmodified form" refers to a functional DNA polymerase that has the amino acid sequence of a naturally occurring polymerase. The term "unmodified form" includes recombinant forms of functional DNA polymerases.

[0094] The term "mutant," in the context of the disclosed DNA polymerases, means a polypeptide, typically recombinant, that contains one or more amino acid substitutions compared to the corresponding naturally occurring or unmodified form of the DNA polymerase.

[0095] "Recombinant" as used herein refers to an amino acid sequence or nucleotide sequence that has been intentionally modified by recombinant methods. As used herein, the term "recombinant nucleic acid" generally refers to a nucleic acid that was originally generated in vitro, by the manipulation of nucleic acids by endonucleases, in a form not normally found in nature. Thus, either a linear isolated mutant DNA polymerase nucleic acid, or an expression vector formed in vitro by ligating DNA molecules that are not normally combined, are considered recombinant for purposes of the present invention. Once a recombinant nucleic acid is made and reintroduced into a host cell, it replicates non-recombinantly, i.e., using the in vivo cellular machinery of the host cell, rather than by in vitro manipulation; however, it is understood that such a nucleic acid, once recombinantly produced, may subsequently be replicated non-recombinantly, but still be considered recombinant for purposes of the present invention. A "recombinant protein" is a protein made using recombinant techniques, i.e., through the expression of a recombinant nucleic acid as described above.

[0096] A nucleic acid is "operably linked" when it is placed into a functional relationship with another nucleic acid sequence. For example, a promoter or enhancer is operably linked to a coding sequence if it affects the transcription of the sequence; or a ribosome binding site is operably linked to a coding sequence if it is positioned so as to facilitate translation.

[0097] The term "vector" typically refers to a double-stranded DNA fragment into which a foreign DNA fragment may be inserted. Alternatively, the vector may be derived from, for example, a plasmid. A vector contains a "replicon" polynucleotide sequence that facilitates autonomous replication of the vector in a host cell. Foreign DNA is defined as heterologous DNA, which is DNA that is not naturally present in the host cell, for example, replicating the vector molecule, encoding a selectable or screenable marker, or encoding a transgene. Vectors are used to transport foreign or heterologous DNA into a suitable host cell. Once inside the host cell, the vector can replicate independently or simultaneously with the host chromosomal DNA, generating multiple copies of the vector and its inserted DNA. In addition, the vector may also contain the necessary elements that allow transcription of the inserted DNA into an mRNA molecule or replicate multiple copies of the RNA from the inserted DNA. Some expression vectors further contain sequence elements adjacent to the inserted DNA that extend the half-life of the expressed mRNA and / or allow translation of the mRNA into a protein molecule. In this way, multiple molecules of mRNA and polypeptides encoded by the inserted DNA can be rapidly synthesized.

[0098] The term "affinity tag" refers to a short polypeptide sequence that allows for detection and / or selection of the polypeptide sequence. For purposes of this disclosure, a recombinant gene encoding a recombinant DNA polymerase may include an affinity tag. Specifically, the affinity tag is typically placed at either the N-terminus or C-terminus of the coding sequence of the DNA polymerase through the use of recombinant techniques. Exemplary affinity tags include polyhistidine (e.g., (His6)), glutathione-S-transferase (GST), HaloTag®, AviTag, calmodulin tag, polyglutamic acid tag, FLAG tag, HA tag, Myc tag, S tag, SBP tag, Softag3, V5 tag, Xpress tag, among others.

[0099] The term "host cell" refers to both unicellular prokaryotes and eukaryotes (e.g., bacteria, yeast, and actinomycetes) when grown in cell culture, as well as unicellular cells derived from higher plants or animals. Exemplary suitable host cells include E. coli, S. cerevisiae, and S. frugiperda.

[0100] As used herein, "percentage of sequence identity" is determined by comparing two optimally aligned sequences over a comparison window, where the portion of the sequence in the comparison window may contain additions or deletions (i.e., gaps) compared to a reference sequence (which does not contain additions or deletions) for optimal alignment of the two sequences. The percentage is calculated by determining the number of positions where an identical nucleic acid base or amino acid residue occurs in both sequences, determining the number of matched positions, dividing the number of matched positions by the total number of positions in the comparison window, and multiplying the result by 100 to determine the percentage of sequence identity.

[0101] The term "identical" or "identity" in the context of two or more nucleic acid or polypeptide sequences refers to two or more sequences or subsequences that are the same. Sequences are "substantially identical" to one another if the sequences have a certain percentage of the same nucleotides or amino acid residues (e.g., at least 20%, at least 25%, at least 30%, at least 35%, at least 40%, at least 45%, at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, or at least 95% identity over a specified region) when compared and aligned for maximum correspondence over a comparison window, or designated region as measured using one of the sequence comparison algorithms described below or by manual alignment and visual inspection. These definitions also refer to the complement of a test sequence. In some cases, the identity exists over a region that is at least about 50 nucleotides in length, or more typically 100 to 500 or 1000 or more nucleotides in length.

[0102] The term "similarity" or "percent similarity" in the context of two or more polypeptide sequences refers to two or more sequences or subsequences that have a certain percentage of identical or similar amino acid residues defined by conserved amino acid substitutions (e.g., 60% similarity over a specified region, optionally 65%, 70%, 75%, 80%, 85%, 90% or 95% similarity) when compared and aligned for maximum correspondence over a comparison window, or a designated region as measured using one of the sequence comparison algorithms described below or by manual alignment and visual inspection. Sequences are "substantially similar" to each other if they are at least 20%, at least 25%, at least 30%, at least 35%, at least 40%, at least 45%, at least 50% or at least 55% similar to each other. In some cases, this similarity exists over a region at least about 50 amino acids in length, more typically at least about 100 to 500 or 1000 or more amino acids in length.

[0103] For sequence comparison, typically, one sequence is used as a reference sequence, and test sequence is compared with the reference sequence.When using sequence comparison algorithm, test and reference sequences are input into computer, partial sequence coordinates are designated as necessary, and sequence algorithm program parameters are designated.Default program parameters are usually used, but alternative parameters can also be designated.Then, based on the program parameters, sequence comparison algorithm calculates the percent sequence identity or similarity of test sequence to reference sequence.

[0104] "Comparison window", as used herein, includes any one of a number of consecutive positions selected from the group consisting of 20 to 600, typically about 50 to about 200, more typically about 100 to about 150, in which a sequence may be compared to a reference sequence of the same number of consecutive positions after optimally aligning the two sequences. Methods of aligning sequences for comparison are well known in the art. Optimal alignment of sequences for comparison can be performed, for example, by the local homology algorithm of Smith and Waterman (Adv. Appl. Math., 2:482, 1970), the homology alignment algorithm of Needleman and Wunsch (J. Mol. Biol., 48:443, 1970), the similarity search method of Pearson and Lipman (Proc. Natl. Acad. Sci. USA, 85:2444, 1988), computerized implementations of these algorithms (e.g., GAP, BESTFIT, FASTA, and TFASTA in the Wisconsin Genetics Software Package, Genetics Computer Group, 575 Science Dr., Madison, Wis.) or by manual alignment and visual inspection (see, for example, Ausubel et al., Current Protocols in Molecular Biology (1995 Suppl.)).

[0105] Suitable algorithms for determining percent sequence identity and percent sequence similarity are the BLAST and BLAST 2.0 algorithms, described in Altschul et al. (Nuc. Acids Res., 25:3389-402, 1977) and Altschul et al. (J. Mol. Biol., 215:403-10, 1990), respectively. Software for performing BLAST analyses is publicly available through publicly available online and Internet databases, as well as the National Center for Biotechnology Information in the National Library of Medicine at the National Institutes of Health (http: / / www.ncbi.nlm.nih.gov / ).

[0106] Rational design of Taq DNA polymerase mutants. Based on the identity of single nucleotide polymorphisms, with modifications most frequently introduced in the past to primers, many strategies have been developed to improve the discrimination of polymerase chain reaction to selectively amplify specific nucleic acid sequences while using naturally occurring DNA polymerases as outlined above. The ability of DNA polymerases to discriminate between matches and mismatches at the 3' end of the primer nucleic acid is limited and varies greatly depending on the identity of the specific base pair present. Another strategy to improve the selectivity of PCR amplification is to modify the properties of DNA polymerases to improve the discrimination between primers that are matched to the template nucleic acid and primers that have terminal mismatches to the template nucleic acid. The present invention provides DNA polymerase mutants with improved mismatch discrimination for base pairing at the 3' end of the primer, resulting in improved specificity of the subsequent amplification reaction.

[0107] The rhPCR method employs blocked-cleavable primers that must be unblocked by the action of RNase H2 before amplification can begin. The enzymatic unblocking step requires cleavage at a single internal RNA base within the primer, typically located at the SNP site. RNase H2 cleaves the RNA at the 5' side, leaving the primer with a 3'-hydroxyl capable of priming PCR. Cleavage by RNase H2 occurs with high efficiency when the primer matches the template and with low efficiency when a mismatch is present due to the SNP. Thus, matched templates are amplified more efficiently than mismatched templates. It is believed that the primary mechanism that allows amplification of mismatched templates begins with alternative cleavage of the substrate (i.e., blocked-cleavable primer) at the 3' side of the RNA residue, resulting in improper priming when a mismatch is present, retention of the RNA base in the primer, and conversion of the PCR product to the primer sequence, which then faithfully replicates as a match in subsequent PCR cycles. The fidelity of the rhPCR process can be improved through improvements in DNA polymerases that limit the ability to initiate DNA synthesis from primers with 3'-RNA residues. The present invention provides DNA polymerase mutants that have a reduced ability to initiate DNA synthesis from a 3'-RNA-containing primer, resulting in improved specificity of the subsequent amplification reaction.

[0108] The present invention includes novel DNA polymerase mutants that have improved discrimination for base identity at the 3' end of a primer nucleic acid and / or DNA polymerase mutants that have reduced priming efficiency from 3' RNA residues.

[0109] A novel design strategy was developed to rationally design DNA polymerase mutants with improved discrimination at the 3'-terminal base of the primer compared to that of native DNA polymerases, limiting their ability to initiate DNA synthesis when mismatches or RNA residues are present. The methods described herein employed Taq DNA polymerase as the parent enzyme; this approach can be applied to other DNA polymerases, especially if their crystal structures are known. The design strategy includes a first component based on theoretical analysis of biophysical, biochemical and genetic information on native DNA polymerases and, to a lesser extent, related polymerases that differ in amino acid sequence. The design strategy includes a second component based on molecular biological and biochemical analysis of known engineered mutant polymerases to assist as a guide in predicting the effect of novel mutations in attempts to rationally engineer new properties into mutant polymerases, in this case improving 3'-nucleotide discrimination.

[0110] In the first step, the enzyme reaction mechanism of Taq DNA polymerase was analyzed based on the published structure-activity relationship (SAR) study of mutations, correlated with the protein structure if known, and predicted using molecular dynamics simulation if not known. The enzyme catalytic mechanism has been reported in the prior art (Patel, PH et al., J. Mol. Biol., 2001, 308:823-837; Li, Y. & Waksman, G., Protein Sci 2001, 10:1225-1233). The amino acid residues located at the C-terminus from position 424 to position 832 are involved in the primer extension catalytic activity of the protein. Taq DNA polymerase binds to the primer-template duplex to form a binary complex. It forms an open ternary complex at the 3' end of the primer in a pocket where the incoming substrate dNTP can bind. If the dNTP is complementary to the template nucleotide, the active site changes conformation; in this case, the α-helix created by residues 659 to 671 rotates toward the site, and the template base rotates toward the incoming dNTP, facilitating the formation of a Watson-Crick base pair. This event "closes" the ternary complex, bringing the α-phosphate group of the dNTP closer to the 3'-OH group of the primer. The oxygen of this hydroxyl group performs a nucleophilic attack on the phosphorus, forming a covalent bond and releasing pyrophosphate. The catalytic activity of Taq DNA polymerase requires the presence of a magnesium ion, which is supposed to facilitate the deprotonation of the attacking hydroxyl group.

[0111] One criterion for the rational design of Taq DNA polymerase mutants with improved 3'-nucleotide discrimination is to provide novel polymerase enzyme variants with normal or near-normal polymerase processivity compared to native DNA polymerase. For this reason, the first step of the analysis serves to narrow the sequence space of amino acids available for changes that should not impair the core enzyme function. For example, residues D610, D785 and E786 form the catalytic core. These carboxylic acid groups are assumed to bind divalent metal ions, which in turn bind and stabilize the incoming dNTPs and the terminal nucleotides of the primer. Mutations of these three essential residues could render the polymerase inactive. Thus, mutant polymerases containing alterations of residues D610, D785 and E786 were excluded from consideration. Similarly, mutations that affect the fidelity of complementary base recognition, such as residues that promote open versus closed ternary complex formation with complementary dNTPs, and template bases, were excluded from consideration.

[0112] An additional criterion for the first stage of the analysis was to identify the amino acid residues of the polymerase in the vicinity of the 3'-terminal nucleotide of the primer. For this purpose, the atomic three-dimensional structure of Taq DNA polymerase available from the prior art (Eom, SH et al., Nature, 1996, 382:278-281; ​​Li, Y. et al., EMBO J., 1998, 17:7514-7525; Doublie, S. et al., Structure 1999, 7:R31-R35; Li, Y. et al., Protein Sci 1998, 7:1116-1123) was selected for analysis. The structure was downloaded from the Protein Data Bank (HM Berman et al., Nucleic Acids Research, 2000, 28:235-242). To show the ternary complex of opening and closing the large fragment of Taq DNA polymerase co-crystallized with primer and template nucleic acid (Li, Y. et al., EMBO J., 1998, 17:7514-7525), we thoroughly analyzed the structures of PDB IDs 2KTQ and 3KTQ, which show the position of the 3' end of the primer in the active site and the interactions with key amino acid residues (Figure 1).

[0113] For visualization of the structure, the hydrogen atom attached to the 2' carbon is replaced with a hydroxyl group for primers modified with 3'-ribonucleotides. Those amino acid residues that are in close proximity to the 2' carbon of the nucleotide at the 3' end of the primer were selected for further analysis. These amino acid residues are listed in Table 2 and are likely to interact with the 3'-terminal nucleotide of the primer. When primer modifications such as OH are attached to the 2' carbon atom of ribose, mutations at these sites may affect the catalytic activity of the polymerase.

[0114] [Table 2]

[0115] Further aspects of this criterion relate to approaches to increase specificity while retaining the catalytic activity of the polymerase. One approach to increase the specificity of Taq DNA polymerase is to reduce the size of the binding pocket so that the modified primer does not fit into it. Any additional chemical groups increase the spatial volume occupied by the 3' nucleotide. To align the atoms for effective catalysis and nucleophilic attack, the active site pocket must be flexible to accommodate an additional atom or atoms, for example, the oxygen of the OH group of an RNA residue. The size of the active site can be reduced by replacing adjacent amino acids with larger amino acids. Further consideration is given to amino acid properties and the ability of these side chains to participate in electrostatic and van der Waals interactions. Amino acids can be classified into groups of positively charged side chains (R, H, K), negatively charged side chains (D, E), uncharged polar side chains (S, T, N, Q), hydrophobic side chains (A, V, I, L, M, F, Y, W) and special side chains (C, G, P). Mutations within a group are likely to be conservative and maintain existing properties, whereas mutations within entire groups or particular groups of amino acids are likely to result in substantial changes in enzyme activity and / or specificity.

[0116] Another approach to increase the 3'-nucleotide discrimination of Taq DNA polymerase is to employ residue substitutions that reduce the flexibility of the binding pocket. Examples include the replacement of amino acid aliphatic side chains with aromatic side chains, which results in a higher energy barrier to alter the rotamer conformation. As explained above, residues of the catalytic core are preferably not altered, and residues spatially close to the catalytic core are given the greatest attention for alteration. For example, it is proposed herein that three non-catalytic core residues, H784, V783 and R573 in Table 2, be substituted for more or less flexible amino acids while maintaining the general physical characteristics of the side chains. These residues show the main interaction with the ribose moiety of the primer through a water-mediated hydrogen bond network. Also, R573 binds to the primer base in the minor groove of the primer-template duplex. Using this strategy, mutants ID1 to ID4 were designed (Table 3). The next mutant, ID 5, Q582K, was designed to alter the interaction with and position of the critical H784 residue. This is seen from the known crystal structure, where Q582 is located on the opposite side of H784 from the oligonucleotide primer. Substitution of Q582H may shift H784 towards the terminal primer nucleotide, resulting in a more constrained binding pocket. Also, the interaction of residue 582 with the penultimate nucleotide may also be affected.

[0117] Also, residues that stack on the incoming dNTP molecule can affect the size of the binding pocket in the polymerase active site. For example, substitution of F667 at this position is known to change the selectivity for the incoming dNTP. For example, F667Y substitution significantly improves the incorporation of dideoxynucleoside triphosphates by Taq DNA polymerase (Tabor, S. & Richardson, CC, Proc. Nat. Acad. Sci. USA, 1995, 92:6339-6343), a useful property of DNA polymerases employed in Sanger method terminator DNA sequencing. Mutant ID6 increases the size of the aromatic side chain of F667 from phenylalanine to tryptophan in an attempt to push the dNTP against the primer terminal ribonucleotide and reduce the ability of the binding pocket to accommodate the 2' hydroxyl group, thereby biasing this mutant to contain a 3'-RNA residue. Mutant ID7 was designed based on a similar conceptual framework. H639 interacts with amino acid F667, and the H639W mutant may also push F667 toward the incoming dNTP.

[0118] Additional mutants were thought to be able to effectively reduce the size of the polymerase's binding pocket. Mutants ID8 to 16 were designed from negative inference analysis based on published studies of "relaxed specificity" mutant polymerases. It has been reported that mutants may change the polymerase specificity towards the ribose of the incoming dNTP. Prior art in which Taq DNA polymerase mutants have been reported evolved from large random libraries either through selection or screening. Chen et al. reported a mutation that allows Taq DNA polymerase to combine dNTPs with large substitutions on the ribose 3' carbon atom (Chen, F. et al., Proc. Nat. Acad. Sci. USA, 2010, 107:1948-1953). This residue was found to be important because it also interacts with F667. Substitution L616A reduces specificity by giving more space to the phenylalanine residue. Mutant ID8 (L616M) was designed to produce the opposite effect. Methionine substitution may slightly increase steric blockage at this site compared to leucine. This restriction may make the active site less able to accommodate extra substituents at the dNTP or primer nucleotides, which may reduce activity of primers containing 3'-RNA or primers with mismatches to the template, possibly occupying more space than primers with perfect mismatches to the template nucleic acid.

[0119] A similar conceptual framework was applied to design Taq DNA polymerase mutant ID9. It was reported that the mutations I614E, E615G relax the active site pocket so that the polymerase can extend the primer using 2'-O-methyl ribonucleoside triphosphates (Fa, M. et al., J. Am. Chem. Soc., 2004, 126:1748-1754). The nature of these mutations is essentially a shift of the glutamic acid at residue 615 to 614. Thus, the shift in the opposite direction, E615L, L616E, may impose constraints at the active site and generate a Taq DNA polymerase mutant that does not accept ribonucleotide residues.

[0120] Another approach to increasing 3'-nucleotide discrimination is to focus on sites of interest identified in Taq DNA polymerase studies that reported amino acid substitutions that increase the fidelity of base selection and reduce incorporation of mismatched base pairs (i.e., mutations that improve replication fidelity). These changes could potentially affect the selectivity of Taq DNA polymerase with respect to modification of terminal primer nucleotides as well. One position reported to improve fidelity involves residue F667 and adjacent amino acids (Suzuki, M. et al., J. Biol. Chem., 2000, 275:32728-32735). Another potential site of interest includes residues 782 to 784 adjacent to the essential aspartic acid residue (Strerath, M. et al., Chem. Bio. Chem., 2007, 8:395-401). Mutants ID10 to ID13 were designed to change the amino acid characteristics at these positions. F667 affects specificity because it interacts with the terminal base of the primer and stacks on the base of the incoming dNTP; this residue resides in the O-helix. Residues I665 and A661 are located on opposite sides of the helix. Mutations of it to larger amino acids (A661E, I665W) can move the O-helix toward the active site, limiting the size of the active pocket and restricting the ability of the polymerase to accept mispaired bases or RNA residues (mutant ID10: A661E, I665W, F667L).

[0121] Also, data obtained from mutagenesis studies of different polymerases can be used to help select positions for modifications, although the use of this data is more difficult due to the absence of crystal structures or the possibility of different effects between polymerases. Polymerase I from Escherichia coli ("E. coli Pol") shows a somewhat similar structure at the active site when compared to Taq DNA polymerase and maintains the same essential catalytic residues. Both protein sequences show a high degree of homology (Li, Y. et al., EMBO J., 1998, 17:7514-7525). Therefore, mutations reported for E. coli DNA polymerase were also considered by extrapolating the amino acid positions to the corresponding positions in Taq DNA polymerase. For example, the triple amino acid substitution Q879P, V880L, H881Q improved base fidelity in E. coli DNA polymerase (Summerer, D. et al., Angew. Chem. Int. Ed., 2005, 44:4712-4715). The substitutions in mutant ID14 include substitutions at Q782, V783, H784 in the Taq DNA polymerase active site that appear to correspond to this triplet of E. coli residues.

[0122] Several additional substitutions in E. coli DNA polymerase are known that decrease or increase the specificity of primer extension (Minnick, DT et al., J. Biol. Chem., 1999, 274:3067-3075). Mutants Q849A and R754A improved fidelity. These have equivalent positions to Q754 and R659, respectively, in the Taq DNA polymerase active site. Arginine 659 has a large effect on the selection of bases complementary to the template bases. This appears to be a general feature in the polymerase A family. For example, in Thermotoga neapolitana polymerase I, the equivalent residue is R722. Mutation of this residue to histidine increases the fidelity of this polymerase (Yang, SW et al., Nucleic Acids Res., 2002, 30:4314-4320). These two residues were also selected for study (mutants ID15 and 16 in Table 3). Mutant ID17 represents a combination of the mutations studied in mutants ID2 and 3. Mutant ID18 represents a modification of triple mutant ID14 (Q782P, V783L, H784Q) reduced to a double mutant (V783L, H784H) by elimination of the Q782 mutation; substitution of a less flexible P for the Q residue could cause significant structural perturbations that alter function, and mutant ID18 is able to avoid this issue. Initial tests indicated that more than one mutation at position H784 showed improved mismatch discrimination, suggesting that this position is generally important for determining primer specificity. A comprehensive study of amino acid substitutions at this site was therefore performed, including mutants ID19-36.

[0123] [Table 3] TIFF0007640606000005.tif93162

[0124] The second component of the design strategy involves molecular biological and biochemical analysis of engineered Taq DNA polymerase mutants to identify novel enzymes with improved 3'-nucleotide discrimination. This requires the expression of native Taq DNA polymerase and a series of engineered mutants in a suitable host, such as the bacterium E. coli. To maximize expression, the codons of the native gene sequence encoding Taq DNA polymerase were modified and optimized for expression in E. coli using the standard codon usage table for this organism (see Codon usage tabulated from the international DNA sequence databases:status for the year 2000, Nakamura, Y., Gojobori, T. and Ikemura, T., (2000), Nucleic Acids Res., 28:292). Codon optimization does not alter the amino acid sequence of the expressed protein. Recombinant forms of the codon-optimized genes encoding the unmodified Taq DNA polymerase peptides were incorporated and cloned into plasmid vectors as artificial genes made from synthetic oligonucleotides using standard methods (Example 1). The plasmid vector for this purpose can be any plasmid vector routinely available in the art. The synthetic recombinant forms of the series of identified desired Taq DNA polymerase mutants (Table 3, mutants ID1-36) were prepared by site-directed mutagenesis of the previously incorporated codon-optimized recombinant native Taq DNA polymerase as a substrate for site-directed mutagenesis (SDM) using techniques well known to those skilled in the art (Example 1). Unmodified and mutant Taq DNA polymerases were prepared from E. coli host cells after introduction of expression vectors containing the corresponding recombinant forms of the genes operably linked to appropriate transcriptional and translational control elements.

[0125] The enzymatic properties of unmodified and mutant Taq DNA polymerases were evaluated for their suitability for use in primer extension assays, thermostability, PCR assays, allele-specific PCR assays, the ability to use primers with 3'-ribonucleotides, and rhPCR assays. The mutant Taq DNA polymerases exhibited one of four categories of enzymatic properties: (1) inactivated polymerase activity; (2) normal polymerase activity; (3) improved 3'-nucleotide discrimination activity but with reduced activity (e.g., reduced processivity); and (4) improved 3'-nucleotide discrimination and normal or near-normal activity (e.g., processivity equivalent to that of the native polymerase).

[0126] Mutant Taq DNA polymerases possessing the fourth category of enzymatic properties exhibited equivalent or increased 3'-mismatch discrimination (i.e., equivalent or increased performance in standard primer extension assays and allele-specific PCR assays when compared to wild-type Taq DNA polymerase); increased 3'-nucleotide discrimination (i.e., reduced primer extension activity from templates containing RNA-containing primers when compared to wild-type Taq DNA polymerase), and increased low-frequency allele discrimination (e.g., improved specificity in rhPCR assays when compared to wild-type Taq DNA polymerase). These mutant Taq The DNA polymerase was designed to detect the following residue positions: (1) A661E;I665W;F667L triple substitution mutant peptide (mutant ID10 in Table 3); (2) V783F single substitution mutant peptide (mutant ID2 in Table 3); H784Q single substitution mutant peptide (mutant ID3 in Table 3); and V783L;H784Q double substitution mutant peptide (mutant ID18 in Table 3), H784A, single substitution mutant peptide (mutant ID20 in Table 3); H784S, single substitution mutant peptide ( H784T, a single substitution mutant peptide (mutant ID 21 in Table 3); H784V, a single substitution mutant peptide (mutant ID 24 in Table 3); H784I, a single substitution mutant peptide (mutant ID 26 in Table 3); H784M, a single substitution mutant peptide (mutant ID 27 in Table 3); H784F, a single substitution mutant peptide (mutant ID 29 in Table 3); and H784Y single substitution mutant peptide (mutant ID 30 in Table 3).

[0127] Thus, the novel design algorithm provides a robust approach to predict mutant DNA polymerases with improved 3'-nucleotide discrimination, as measured by polymerase activity in allele-specific PCR, low-frequency allele detection assays, and rhPCR assays that utilize templates with or without a 3'-RNA residue in the primer. Specifically, residues V783 and H784 were identified as key residues that affect the ability of the polymerase to probe the 3'-base state of the primer oligonucleotide (e.g., whether the residue matches or does not match the template, and / or whether the residue is DNA or RNA). The importance of these residues in polymerase function has not been recognized previously. In addition to the mutations directly tested in the examples, the present invention also contemplates other amino acid substitutions at these two positions, or double mutations that affect both the V783 and H784 sites.

[0128] The properties of these mutants are further described in the Examples presented herein. Importantly, however, the design strategy employed herein can access functional space for novel Taq DNA polymerase mutants that were previously unrecognized or anticipated, or that were not obtained using other approaches (e.g., previous attempts using phylogenetic comparative analysis or random mutagenesis).

[0129] Evaluation of Taq DNA polymerase mutants at residue positions 783 and 784 The present disclosure demonstrates that mutations at residue positions 783 and / or 784 result in active Taq DNA polymerase mutants with increased template discrimination activity compared to unmodified Taq DNA polymerase. Thus, the entire sequence space including all possible single amino acid substitutions at individual positions 783 or 784, as well as all possible double amino acid substitutions at both positions 783 and 784, is within the scope of the present disclosure relating to Taq DNA polymerase. Thus, active Taq DNA polymerase mutants selected from the set of 19 single residue 783 mutants, 19 single residue 784 mutants (Table 3, mutant IDs 19-30) and 361 double residue 783 / 784 mutant mutants that also have increased template discrimination activity are within the scope of the present disclosure.

[0130] Because Taq DNA polymerase is a thermostable enzyme, one facile approach to screen a candidate collection of 399 single and double substitution mutants at residue positions 783 and 784 is to perform a PCR assay with pretreated samples encoding candidate Taq DNA polymerase mutant enzymes. Samples can be selected individual colonies or corresponding microcultures (e.g., 50 μL to 1.0 mL cultures) obtained from individual colonies transformed with recombinant DNA expressing the desired recombinant Taq DNA polymerase mutant gene. The pretreatment regimen can include preincubating the samples at 70-95°C, followed by clarifying the supernatant to remove denatured cell debris. For samples expressing thermostable polymerase activity under standard PCR assay conditions, the corresponding recombinant DNA can be further characterized to confirm the desired recombinant Taq DNA polymerase mutant genotype and the sequence of the purified polymerase protein for further biochemical analysis. For purposes of this disclosure, a Taq DNA polymerase mutant that expresses thermostable polymerase activity at a level of at least 0.01 that expressed by a wild-type Taq DNA polymerase under equivalent PCR assay conditions can be considered to have thermostable polymerase activity.

[0131] Evaluation of other selective polymerase candidate mutants functionally homologous to Taq DNA polymerase at residues 783 and 784. Comparative phylogenetic analysis tools can be used to identify the sequence space of other thermoactive polymerases that have sequence information homologous to unmodified Taq DNA polymerase at residue positions corresponding to V783 and H784. As explained above, a strong prediction of comparative phylogenetic analysis is that structural sequences shared between DNA polymerases across phylogenetically diverse species are conserved for functional reasons. If the identified V783 / H784 residues of Taq DNA polymerase are invariant in sequence identity among wild-type polymerases from diverse species, the observation strongly supports the conclusion that the specific mutation-selected nature of amino acid substitutions at those positions results in the observed increased template discrimination activity of the engineered Taq DNA polymerase mutants disclosed herein.

[0132] Example 11 provides an exemplary BLAST search using the Taq DNA polymerase sequence encompassing positions V783 and H784 as a comparison window to identify candidate wild-type DNA polymerases from other species that share broad sequence identity with Taq DNA polymerase. As further detailed in Example 11, the BLAST results revealed that virtually all identified DNA polymerases from various species maintained Val and His at positions orthologous to V783 and H784 of Taq DNA polymerase. Thus, the BLAST results confirm natural counterselection against DNA polymerases with increased template discrimination activity and provide strong evidence that the disclosed engineered Taq DNA polymerase mutants with these properties are novel and non-obvious. As observed with the engineered Taq DNA polymerase mutants, each of the identified non-Taq DNA polymerases represents a sequence space in which engineered mutant enzymes may arise with increased template discrimination activity compared to their respective unmodified counterparts.

[0133] In cases where comparative phylogenetic analysis cannot access the sequence space of organisms that are more evolutionarily distant, comparative biophysical crystallographic analysis can provide clues to related sequence residues that have homologous functions to Taq DNA polymerase V783 and H784. As explained above, the Q782, V783 and H784 residue triplet of Taq DNA polymerase was selected for analysis based on the corresponding triple amino acid substitutions Q879P, V880L and H881Q of E. coli DNA polymerase, which have improved base fidelity and an active site structure similar to Taq DNA polymerase. Conversely, based on the significantly increased template discrimination activity of the Taq DNA polymerase mutants of V783 and H784 compared to wild-type Taq DNA polymerase, the present invention contemplates that the corresponding substitutions at V880 and H881 of E. coli DNA polymerase have increased template discrimination activity compared to wild-type E. coli DNA polymerase.

[0134] Identification and characterization of non-VH-related polymerase mutants with enhanced template discrimination activity The aforementioned collection of DNA polymerases share extensively conserved sequences in the regions corresponding to V783 and H784 of Taq DNA polymerase ("VH-related polymerases"). Comparative biophysical analysis is useful for identifying wild-type DNA polymerases that have different amino acid sequences in the functionally homologous positions as V783 and H784 of Taq DNA polymerase ("non-VH-related DNA polymerases"). The present disclosure contemplates engineering mutant polymerases with increased template discrimination activity from these non-VH-related DNA polymerases in the same manner as disclosed for VH-related DNA polymerases. Candidate non-VH residues for site-directed mutagenesis and analysis by increased template discrimination activity assay include those residues within 0.40-0.45 nm of C2' of the primer terminal residue as revealed in the polymerase:template co-crystal structure.

[0135] Combination of site-specific Taq DNA mutants with deletions of the 5'-exonuclease domain The present invention discloses novel Taq DNA polymerase mutants that show improved discrimination of mismatches located at the 3' residue of a primer oligonucleotide and / or discrimination against the presence of an RNA residue at the 3' end of the primer oligonucleotide. Improved mismatch discrimination has been described for the "KlenTaq" deletion mutant of Taq DNA polymerase, which completely removes the domain with 5'-exonuclease activity (Barnes, WM et al., Gene, 112:29-35, 1992). Combining the novel mutants of the present invention with the KlenTaq 5'-exonuclease domain deletion results in further improvement in mismatch discrimination (Examples 18 to 22). However, this combination resulted in a reduction in enzyme activity that may reduce the usefulness of this family of double mutants. In some situations, the increased discrimination of these mutants is advantageous, especially when the amplicon size is small and limited processivity can be tolerated.

[0136] Reaction mixture In another aspect, a reaction mixture is provided that includes a polymerase with increased 3' nucleotide discrimination activity. The reaction mixture can further include, for example, reagents for use in nucleic acid amplification methods (e.g., PCR, RT-PCR, rhPCR), DNA sequencing procedures, or DNA labeling procedures. For example, in certain embodiments, the reaction mixture includes a buffer suitable for a primer extension reaction. The reaction mixture also includes a template nucleic acid (DNA and / or RNA), one or more primer or probe polynucleotides, nucleoside triphosphates (e.g., including deoxyribonucleotides, ribonucleotides, labeled nucleotides, unconventional nucleotides), salts (e.g., Mn 2+ , Mg 2+), and a label (e.g., a fluorophore). In some embodiments, the reaction mixture further comprises a double-stranded DNA binding dye, such as SYBR Green, or a double-stranded DNA intercalating dye, such as ethidium bromide. In some embodiments, the reaction mixture further comprises a 5' sense primer capable of hybridizing to a given polynucleotide template under primer extension conditions, or a primer pair comprising a 5' sense primer and a corresponding 3' antisense primer. In certain embodiments, the reaction mixture further comprises a fluorescent FRET hydrolysis probe, such as a Taqman® or PrimeTime® probe, for detection of the amplified template nucleic acid. In some embodiments, the reaction mixture contains two or more primers that are fully complementary to the single nucleotide polymorphism or multiple nucleotide polymorphisms. In some embodiments, the reaction mixture contains alpha-phosphorothioate dNTPs, dUTPs, dITPs, and / or labeled dNTPs, such as fluorescein or cyanine dye family dNTPs. In some embodiments, the reaction mixture contains a blocked cleavable primer and RNase H2.

[0137] kit In another aspect, a kit is provided for use in the primer extension method described herein. In some embodiments, the kit is intended for ease of use and includes at least one container providing a DNA polymerase of the invention with increased 3'-nucleotide discrimination in accordance with the present disclosure. It may also include one or more additional containers providing an additional reagent or reagents. Such additional containers may include any reagent or other element recognized by those skilled in the art for use in a primer extension procedure according to the methods described above, including, for example, reagents for use in a nucleic acid amplification procedure (e.g., PCR, RT-PCR, rhPCR), a DNA sequencing procedure, or a DNA labeling procedure. For example, in certain embodiments, the kit further includes a container providing a 5' sense primer or a primer pair comprising a 5' sense primer and a corresponding 3' antisense primer capable of hybridizing to a given polynucleotide template under primer extension conditions. In some embodiments, the kit includes one or more containers containing one or more primers that are fully complementary to a single nucleotide polymorphism or multiple nucleotide polymorphisms, where the primers are useful for multiple reactions as described above. In some embodiments, the reaction mixture contains one or more containers containing a blocked-cleavable primer. In some embodiments, the reaction mixture contains one or more containers containing RNase H2. In other non-mutually exclusive variations, the kit includes one or more containers providing nucleoside triphosphates (conventional and / or non-conventional). In specific embodiments, the kit includes alpha-phosphorothioate dNTPs, dUTP, dITP and / or labeled dNTPs, such as fluorescein or cyanine dye family dNTPs. In yet other non-mutually exclusive embodiments, the kit includes one or more containers providing buffers suitable for primer extension reactions. In some embodiments, the kit includes one or more labeled or unlabeled probes. Exemplary probes include dual-labeled FRET (fluorescence resonance energy transfer) probes and molecular beacon probes.In another embodiment, the kit contains aptamers, for example, aptamers for a hot start PCR assay.

[0138] The present disclosure contemplates a kit that provides novel DNA polymerases with enhanced template discrimination activity. As shown in more detail in the examples, each DNA polymerase can exhibit a unique feature of enhanced template discrimination activity. Certain DNA polymerases may exhibit relatively greater 3' nucleotide discrimination compared to other activities (3' mismatch discrimination and low frequency allele discrimination). Meanwhile, other DNA polymerases can exhibit relatively greater low frequency allele discrimination compared to other activities (3' nucleotide discrimination and 3' mismatch discrimination), and still other DNA polymerases can exhibit relatively greater low frequency allele discrimination compared to other activities (3' nucleotide discrimination and 3' mismatch discrimination). Thus, the kit can include individual containers of a particular DNA polymerase with an activity profile optimally adapted to a particular enhanced template discrimination activity for a particular assay platform. Alternatively, the kit can include a single container that includes multiple DNA polymerases with activity profiles optimally adapted to adjust the enhanced template discrimination activity as required for multiple assay platforms. EXAMPLES

[0139] The present invention will be further illustrated with reference to the following examples, however, it should be noted that these examples, like the above-mentioned embodiments, are illustrative and should not be construed as limiting the scope of the present invention in any way.

[0140] [Example 1] Cloning and expression of a codon-optimized DNA polymerase from Thermus aquaticus The amino acid sequence and gene sequence of Taq DNA polymerase are known (Table 1, SEQ ID NOs: 1 and 2). Because codon usage varies between organisms, the codons of the native gene sequence encoding Taq DNA polymerase were optimized for expression in E. coli using standard codon usage tables (Codon usage tabulated from the international DNA sequence databases: status for the year 2000. Nakamura, Y., Gojobori, T. and Ikemura, T. (2000) Nucleic Acids Res. 28:292); synonymous codon changes were introduced to avoid repeated use of the same codon throughout the 20 amino acid stretch. The recombinant codon-optimized gene encoding the Taq DNA polymerase unmodified peptide was assembled from synthetic oligonucleotides using standard methods. The gene was made in three fragments, each of which was subcloned into a plasmid vector; the sequences are shown in Table 4 (SEQ ID NOs: 3-5). Sequence identity was confirmed by Sanger DNA sequencing. The three Taq DNA polymerase subfragments were assembled together using the Gibson assembly method (Gibson, DG et al., Nature Methods, pp. 343-345 (2009)) and cloned into the plasmid expression vector pET-27b(+) using terminal NdeI and NotI restriction sites to generate the final full-length codon-optimized Taq DNA polymerase gene (referred to as "OptiTaq"). The sequence was confirmed by Sanger DNA sequencing; the sequence is shown in Table 4 (SEQ ID NO:6). The translated amino acid sequence of the new codon-optimized gene is identical to the native Taq DNA polymerase (Table 1, SEQ ID NO:1).

[0141] [Table 4] TIFF0007640606000007.tif76168TIFF0007640606000008.tif191169

[0142] [Example 2] Generation of codon-optimized Taq DNA polymerase mutants Eighteen mutant versions of Taq DNA polymerase (Table 3, MUT ID1-18) were generated by site-directed mutagenesis of cloned OptiTaq codon-optimized Taq DNA polymerase. Specific mutations were introduced into the OptiTaq sequence using PCR site-directed mutagenesis (Weiner MP et al., Gene., 151(1-2):119-23 (1994)). Each mutagenesis reaction employed 10 pmol of two complementary oligonucleotides (Table 5) containing the desired base changes annealed to double-stranded OptiTaq plasmid (20 ng), 5U KOD DNA polymerase (Novagen-EMD Chemicals, San Diego, CA), 1.5 mM MgSO4 in 1× KOD PCR buffer. Thermal cycling parameters were 95°C for 3 min (95°C for 20 s, 55°C for 20 s, 70°C for 2.5 min) followed by 16 cycles of 4 min soak at 70°C. After PCR site-directed mutagenesis, the amplified products were treated with 10 U of DpnI (NEB, Ipswish, MA) for 1 h at 37°C, followed by inactivation at 80°C for 20 min. One-hundred-tenths of the digested material was transformed into XL-1 Blue competent bacteria. Bacterial clones were isolated, plasmid DNA was prepared, and individual mutations were confirmed by Sanger DNA sequencing. All mutants were persisted in the pET-27b(+) expression vector suitable for expressing recombinant proteins in E. coli.

[0143] [Table 5] TIFF0007640606000010.tif194170

[0144] [Example 3] Expression of recombinant Taq DNA polymerase The following examples demonstrate the expression of recombinant Taq DNA polymerase unmodified and mutant peptides. The synthetic gene sequences from Examples 1, 2, and 12 were cloned into the pET-27b(+) expression vector (Novagen, EMD Biosciences, La Jolla, Calif.). This vector places six histidine residues (together comprising the "His-tag") at the carboxy terminus of the expressed peptide, followed by a stop codon. The "His-tag" is a Ni-tag that is well known to those of skill in the art. 2+ The use of affinity chromatography methods allows for the rapid and simple purification of recombinant proteins. Alternatively, the synthetic genes could be expressed in native form without His-tags and purified using size-exclusion chromatography, anion-exchange chromatography, or other such methods that are also well known to those skilled in the art.

[0145] BL21(DE3) competent E. coli cells (Novagen) were transformed with approximately 1 ng of each plasmid. Briefly, plasmids were added to cells on ice and gently agitated. After incubation on ice for 5 min, cells were heat shocked at 42°C for 30 s and then placed back on ice for 2 min. SOC (80 μL) was added to the transformed cells at room temperature followed by growth at 37°C for 1 h with agitation at 250 rpm. Cells were plated (20 μL) onto pre-warmed LB / Kan plates (Luria Broth agar plates supplemented with 50 μg / mL kanamycin) at 37°C overnight. The following morning, a single colony was picked and cultured at log phase (OD ) in 10 mL of LB / Kan broth (50 μg / mL). 600Cells were grown (37°C, 250 rpm) until a pH of 0.3-0.9). Cells were then transfected with the Overnight Expression™ Automated Transfection System 1 (Novagen) in Terrific Broth at 37°C, 250 rpm according to the manufacturer's recommended protocol. Culture volumes were 100 mL for wild-type OptiTaq and 200 mL for mutants. Growth saturation was reached after 18 hours and cultures were pelleted at 10,000 x g for 10 minutes in a Beckman Avanti™ J-25 centrifuge. The pellet (approximately 6 g) was lysed using 30 mL of BugBuster® Protein Expression Reagent (Novagen), 30 kU rLysozyme™ Solution (Novagen) and 1500 U of DNase I (Life Technologies, Grand Island, NY) according to the manufacturer's instructions to release soluble proteins and degrade nucleic acids. After centrifugation at 15,000 x g for 20 min to remove cellular debris, the lysate was heated at 75°C for 15 min to inactivate DNase I and other cellular nucleases. The lysate was then spun at 15,000 x g for 20 min to precipitate denatured proteins. The heat denaturation and centrifugation steps provide a significant purity enhancement of the recombinant enzyme. Both the "total" and "soluble" fractions of the bacterial lysate were analyzed using SDS4-20% polyacrylamide gel electrophoresis at 125V for 1 h. Proteins were visualized by Coomassie blue staining for 1 h, followed by 3-4 rounds of destaining until the protein bands disappeared.

[0146] The recovered soluble proteins were then bound to Ni-His binding resin (Novagen). 2+The affinity column was passed through and eluted using a buffer containing 200 mM imidazole (200 mM imidazole, 500 mM NaCl, 20 mM Tris-HCl, pH 7.9). The purified protein (approximately 6 mL) was then concentrated to approximately 200 μL at 3210×g in a Beckman Coulter 6R benchtop centrifuge swinging bucket rotor using Amicon Ultra-15, PLGC Ultracel-PL Membrane, 10 KDa concentrators (EMD Millipore, Billerica, MA) and stored at −20° C. until dialysis. The concentrated protein was then dialyzed against storage buffer (20 mM Tris pH 7.5, 100 mM sodium chloride, 1 mM DTT, 0.1 mM EDTA, 50% glycerol, 0.1% Triton X-100) overnight at 4°C, followed by 3×2 h (each time with a 1000-fold ratio of protein solution to dialysis buffer). The final purified protein was stored at -20°C. Using this protocol, the yield of a 100 mL culture autotransferred was approximately 1.2 mg / 67.6 μM / 12,168 pmol of purified soluble protein for OptiTaq. Similar yields were obtained for the mutant DNA polymerases.

[0147] To determine protein concentration, samples were run alongside known amounts of BSA (bovine serum albumin) using SDS 4-20% polyacrylamide gel electrophoresis for 1 h. Proteins were visualized with Coomassie blue staining for 1 h, followed by 3-4 rounds of destaining until protein bands disappeared. Band intensity was analyzed using ImageJ software (National Institutes of Health, Bethesda, MD).

[0148] To assess the purity and quality of the recombinant protein preparations, 500 ng of each recombinant protein (wild-type OptiTaq and each mutant) was separated on a 4-20% SDS-PAGE gel, stained with Coomassie blue and visualized. All recombinant proteins migrate at the appropriate position on the gel for a protein with a molecular weight of 97.1 kDa. The preparations show a relatively high purity, with some additional species being detected. Gel images are shown in Figures 2A, 2B, 2C and 2D. Similar gels were run for MUT IDs 22 (H784T), 24 (H784V), 30 (H784Y), 31 (H784W) and 35 (H784K) and single bands corresponding to the desired recombinant proteins were visualized (data not shown).

[0149] The purified enzymes were tested for nuclease contamination using DNaseAlert™ and RNaseAlert® Nuclease Detection Kits (Integrated DNA Technologies, Coralville, IA) according to the manufacturer's recommended protocols. All enzyme preparations were found to be free of nuclease contamination.

[0150] [Example 4] Characterization of the properties of 18 mutant Taq DNA polymerases in PCR. The 18 mutant Taq DNA polymerase enzymes described in Example 3 were characterized for polymerase activity and ability to discriminate between 3'-RNA residues in primer oligonucleotides.

[0151] The unit activity of purified wild-type protein was determined by comparing the performance in qPCR of known amounts of OptiTaq and each mutant compared to a commercially available non-hot start Taq DNA polymerase, Taq-B DNA polymerase (Enzymatics, Beverly, MA). Quantitation cycle values ​​(Cq, the amplification cycle number at which a positive signal is first detected) and amplification curve shapes were analyzed to determine the nanogram amounts at which both enzymes performed similarly within the suboptimal range for each. Using these nanogram amounts and the known unit values ​​for Taq-B DNA polymerase, relative activity unit values ​​could be extrapolated for all of the mutant DNA polymerase enzymes that had sufficient activity to support PCR.

[0152] The following reaction conditions were employed: 1x qPCR buffer (20 mM Tris pH 8.4, 50 mM KCl, 3 mM MgCl, 0.01% Triton-X100), 800 µM dNTPs (200 µM each), 500 nM For primer (Hs HPRT F517, SEQ ID NO: 43), 500 nM Rev primer (Hs HPRT R591, SEQ ID NO: 44), 250 nM probe (Hs HPRT P554, SEQ ID NO: 45), 2x10 3copy linear cloned plasmid template (HPRT-targ, SEQ ID NO: 46). The amount of DNA polymerase added to each reaction was varied as follows: for wild type (OptiTaq), reactions were set up using 10, 1, 0.1, 0.01, 0.001 U / μL (220, 22, 2.2, 0.22 or 0.022 ng per 10 μL reaction). Mutant polymerases were run at similar concentrations. Those mutant enzymes showing polymerase activity were also titrated more finely, testing 220, 22, 10.6, 4.8, 2.2, 1.1, 0.48 and 0.22 ng of protein per 10 μL reaction. Enzyme dilutions were made in enzyme dilution buffer (20 mM Tris pH 7.5, 100 mM NaCl, 1 mM DTT, 0.1% Triton-X100, 1 mg / mL BSA, 10% glycerol). Reactions were performed in 384-well format on a BIO-RAD CFX384™ real-time system (BIO-RAD, Hercules, CA) using the following cycling parameters: 95° C. for 30 seconds, followed by 60 cycles of [95° C. for 15 seconds, followed by 60° C. for 1 minute]. Detection was achieved using a fluorescence quenched probe (5'-nuclease assay format; note that the mutations introduced in this series of Taq mutants are not in the 5'-nuclease domain). The sequences of primers, probes and templates (plasmid inserts) are shown in Table 6.

[0153] [Table 6]

[0154] These 18 Taq DNA polymerase mutants were characterized as outlined above. The results are summarized in Table 7. Six mutants, including mutants ID4, 5, 9, 12, 13, and 17, did not show detectable DNA polymerase activity and were not studied further. Six mutants, mutants ID6, 7, 11, 14, 15, and 16, had DNA polymerase activity; however, the processivity was reduced 4-50 fold compared to the wild-type enzyme. Six mutants, mutants ID1, 2, 3, 8, 10, and 18, showed DNA polymerase activity similar to wild-type OptiTaq.

[0155] [Table 7]

[0156] A subset of these mutant Taq DNA polymerases that showed DNA polymerase activity were studied for their ability to discriminate between primers bearing 3'-DNA versus 3'-RNA residues, in comparison to the wild-type OptiTaq enzyme. Real-time PCR was performed as previously described, employing in the reaction an amount of each mutant DNA polymerase equivalent to 0.5 units of wild-type OptiTaq per 10 μL reaction. The following reaction conditions were employed: 1x qPCR buffer (20 mM Tris pH 8.4, 50 mM KCl, 3 mM MgCl2, 0.01% Triton-X100), 800 µM dNTPs (200 µM each), 500 nM For primer (Hs SFRS9 F569rU, SEQ ID NO: 47), 500 nM Rev primer (Hs SFRS9 R712 rA, SEQ ID NO: 48), 250 nM probe (Hs SFRS9 P644, SEQ ID NO: 49), 2x10 3Copy linear cloned plasmid template (SFRS9-targ, SEQ ID NO:50). Reactions were performed in 384-well format on a BIO-RAD CFX384™ Real-Time System (BIO-RAD, Hercules, CA) using the following cycling parameters: 95° C. for 30 seconds, followed by 60 cycles of [95° C. for 15 seconds, followed by 60° C. for 1 minute]. Detection was achieved using a fluorescence quenched probe (5'-nuclease assay format). Primer, probe and template (plasmid insert) sequences are shown in Table 8.

[0157] [Table 8]

[0158] Twelve Taq DNA polymerase mutants that supported PCR were tested for their ability to use 3'-RNA modified primers as outlined above. The results are summarized in Table 7. Mutants ID1 and 8 showed no difference between primers with 3'-DNA compared to 3'-RNA residues. Mutants ID2, 3, 6, 7, 10, 11, 14, 15, 16 and 18 showed amplification retardation using 3'-RNA primers. Thus, the rational design strategy employed herein was successful and Taq DNA polymerase mutants were identified and differentiated for priming from 3'-RNA residues. Those mutants that showed some retardation with RNA priming and showed high processivity were studied for improvement in primer 3'-residue mismatch discrimination.

[0159] [Example 5] Improved mismatch discrimination in allele-specific PCR using mutant Taq DNA polymerase. Of the 18 mutant enzymes studied in Example 4, mutants ID2, 3, 10 and 18 showed the ability to discriminate 3'-RNA residues in the primer and retained high enzyme activity / processivity. These four mutants were studied for their ability to discriminate 3'-terminal DNA mismatches compared to wild-type OptiTaq DNA polymerase using an allele-specific qPCR assay. Amplification reactions were performed on synthetic oligonucleotide templates, in this case with a single base change (SNP) placed at the 3'-end of the reverse primer. Synthetic templates with each of the four possible bases at this position were employed. Reverse primers with each of the four possible bases at the 3'-end were employed. The relative amplification efficiency of all pairwise combinations was evaluated using qPCR.

[0160] Quantitative allele-specific real-time PCR (AS-qPCR) yielded 2 × 10 3The reaction was carried out in a 10 μL reaction volume in a 384-well format using a 103 bp synthetic template (SEQ ID NO:51-54) of copies. The final reaction conditions used were 20 mM Tris-HCL (pH 8.4 at 25° C.), 50 mM KCL, and 3 mM MgCl2, 0.01% Triton X-100, 800 μM total dNTPs, as well as 200 nM of the universal forward primer (SEQ ID NO:60), 200 nM of the reverse primer (separate reactions were set up for each of the allele-specific primers SEQ ID NO:55-58 or the control universal primer SEQ ID NO:59), and 200 nM of the 5′ nuclease detection probe (SEQ ID NO:61). Each allele-specific primer was tested on each SNP template. Reactions utilized either 0.5U (10.8ng / 11.1nM / 111fmol) of wild type OptiTaq DNA polymerase or 0.5U of one of the four Taq DNA polymerase mutants studied (MUT ID No.2 V783F, MUT ID No.3 H784Q, MUT ID No.10 A661E I665W F667L or MUT ID No.18 V783L H784Q). Amplifications were performed on a CFX384™ C1000™ Thermocycler System (Bio-Rad, Hercules, CA) using the following cycling parameters: initial denaturation at 95°C for 30 seconds, followed by 60 cycles of 95°C for 10 seconds, followed by 60 cycles of 60°C for 30 seconds. The oligonucleotide reagents used in this example are shown in Table 9.

[0161] [Table 9] TIFF0007640606000015.tif77160

[0162] Initially, all reactions were performed in triplicate. Similar results were obtained for all replicates when wild-type OptiTaq was used. However, the results showed a greater variation for the mutant polymerase. Therefore, to obtain statistically meaningful results, each reaction was performed 96 times for the mutant polymerase and 81 times for the wild-type enzyme. ΔCq values ​​were calculated as the Cq value obtained for each mismatched base pair minus the Cq value obtained for the matched base pair (ΔCq=Cqmismatch-Cqmatch). The ΔCq values ​​for all 96 replicates were averaged and the standard deviation was calculated. The results are shown in Table 10 and summarized graphically in Figures 3A and 3B. Note that the reverse primer is an allele-specific primer. Thus, the "Syn Rev T" primer (SEQ ID NO:55) is a perfect match for template A (SEQ ID NO:51), and so on.

[0163] [Table 10] TIFF0007640606000017.tif139166

[0164] Wild-type OptiTaq showed an average ΔCq for AS-qPCR in this synthetic amplicon system of 4.2 with a range of 1.4 to 8.0. Mutant ID2 (V783F) showed an average ΔCq of 9.4 with a range of 3.5 to 17.9. Mutant ID3 (H784Q) showed an average ΔCq of 9.9 with a range of 4.6 to 21.2. Mutant ID10 (A661E, I665W, F667L) showed an average ΔCq of 10.9 with a range of 3.3 to 19.9. Mutant ID18 (V783L, H784Q) showed an average ΔCq of 12.4 with a range of 4.9 to 26.6. Thus, in all pairwise combinations of the four template bases and the four 3'-terminal primer bases, the mutant Taq DNA polymerases of the invention showed greater discrimination against mismatches than the wild-type OptiTaq DNA polymerase. The magnitude of improvement for each mismatch pair is defined by ΔΔCq, the difference in discrimination between the mutant and wild-type enzymes (ΔΔCq=ΔCq mutant-ΔCq wild-type). ΔΔCq values ​​were calculated and are shown in Table 11.

[0165] [Table 11] TIFF0007640606000019.tif87167

[0166] Mutant ID2 (V783F) showed an average ΔΔCq of 5.2 compared to wild-type OptiTaq. Mutant ID3 (H784Q) showed an average ΔΔCq of 5.7 compared to wild-type OptiTaq. Mutant ID10 (A661E, I665W, F667L) showed an average ΔΔCq of 6.7 compared to wild-type OptiTaq. Mutant ID18 (V783L, H784Q) showed an average ΔΔCq of 8.2 compared to wild-type OptiTaq. Thus, each of the mutant Taq DNA polymerases of the invention showed a significant improvement in mismatch discrimination compared to wild-type OptiTaq, and importantly, mismatch discrimination was improved for all possible mismatch base pair combinations. Overall, mutant ID18 (V783L, H784Q) showed the best SNP discrimination within the set of four mutant enzymes studied in this example using the AS-PCR assay.

[0167] [Example 6] Discrimination of primer 3'-RNA residues by Taq DNA polymerase mutants All 18 Taq DNA polymerase mutants were screened in Example 4 for their ability to discriminate against priming from 3'-RNA residues. The four mutants studied in AS-PCR in Example 5 (MUT IDs 2, 3, 10 and 18) that showed good 3'-mismatch discrimination were studied in more detail in this example for their ability to discriminate against the presence of a 3'-terminal RNA residue in the primer and examined for possible base-specific effects. Amplification reactions were performed on synthetic oligonucleotide templates, in this case with a single base altered (SNP) placed at the 3' end of the reverse primer. Synthetic templates with each of the four possible bases at this position were employed. Reverse primers with each of the four possible RNA bases at the 3' end were employed and results were compared to control reactions using primers with each of the four possible DNA bases at the 3' end. Relative amplification efficiencies were assessed using qPCR.

[0168] Quantitative real-time PCR (qPCR) yielded 2 × 10 3 The reaction was carried out in a 10 μL reaction volume in a 384-well format using a 103 bp synthetic template (SEQ ID NO:51-54) of copies. The final reaction conditions used were 20 mM Tris-HCL (pH 8.4 at 25° C.), 50 mM KCL, and 3 mM MgCl2, 0.01% Triton X-100, 800 μM total dNTPs, as well as 200 nM of the universal forward primer (SEQ ID NO:60), 200 nM of the reverse primer (separate reactions were set up for each of the four 3'-RNA primers SEQ ID NO:62-65, each of the four 3'DNA primers SEQ ID NO:55-58, or the control universal primer SEQ ID NO:59), and 200 nM of the 5' nuclease detection probe (SEQ ID NO:61). Each primer was tested only on the complementary template (mismatch conditions were not tested). Reactions utilized either 0.5U (10.8ng / 11.1nM / 111fmol) of wild-type OptiTaq DNA polymerase or 0.5U of one of the four Taq DNA polymerase mutants studied (MUT ID No.2 V783F, MUT ID No.3 H784Q, MUT ID No.10 A661E I665W F667L or MUT ID No.18 V783L H784Q). Amplifications were performed on a CFX384™ C1000™ Thermocycler System (Bio-Rad, Hercules, CA) using the following cycling parameters: initial denaturation at 95°C for 30 seconds, followed by 60 cycles of 95°C for 10 seconds, followed by 60 cycles of 60°C for 30 seconds. The oligonucleotide reagents used in this example are shown in Table 12. A total of 96 replicates were performed for each pairwise combination.

[0169] [Table 12] TIFF0007640606000021.tif68160

[0170] The average Cq values ​​were calculated for the 96 replicate sets. ΔCq values ​​were calculated as the difference between the average Cq values ​​of the 3'-RNA primer reactions and the average Cq values ​​of the 3'-DNA primer reactions (ΔCq=Cq3'RNA-Cq3'-DNA). Higher ΔCq values ​​indicate a greater degree of discrimination against priming from the 3'-RNA primer. The results are shown in Table 13 and summarized graphically in Figure 4.

[0171] [Table 13] TIFF0007640606000023.tif128164

[0172] Wild-type OptiTaq did not show any significant discrimination between 3'-DNA and 3'-RNA primers. However, all four mutant Taq DNA polymerases showed reduced priming efficiency when 3'-RNA primers were used. Thus, the goal of creating a novel polymerase that discriminates against 3'-RNA residues in the primer was achieved using the intelligent mutagenesis design strategy described herein. Interestingly, the magnitude of discrimination was much greater for RNA pyrimidine residues (rC or rU) than for RNA purine residues (rA or rG).

[0173] [Example 7] Improved mismatch discrimination in rhPCR using mutant Taq DNA polymerase. RNase H-based PCR (rhPCR) employs the enzyme RNase H2 to convert blocked cleavable oligonucleotides that are incapable of priming DNA synthesis into a form that can prime DNA synthesis and initiate PCR. Blocked cleavable oligonucleotides or blocked cleavable primers contain a single RNA residue near the 3' end of the oligonucleotide (containing the cleavage site) and are modified at or near the 3' end such that the primer is unable to prime DNA synthesis and / or loses template function, making it unsuitable to support PCR even if primer extension could occur. This method is used for genotyping (SNP discrimination) and relies on the ability of RNase H2 to discriminate between base pair matches versus mismatches at the RNA base cleavage site when hybridized to the target nucleic acid. In rhPCR, SNP discrimination occurs at the primer unblocking step and not at the primer extension step (in AS-PCR, discrimination occurs at the primer extension step).Examples of enzyme cleavage strategies, similar RNase H strategies, and methods for blocking primer extension or inhibiting template function, thereby disabling PCR, are described in U.S. Pat. No. 7,112,406 by Behlke et al., entitled "POLYNOMIAL AMPLIFICATION OF NUCLEIC ACIDS"; U.S. Pat. No. 5,763,181 by Han et al., entitled "CONTINOUS FLUOROMETRIC ASSAY FOR DETECTING NUCLEIC ACID CLEAVAGE"; U.S. Pat. No. 7,135,291 by Sagawa, entitled "METHOD OF DETECTING NUCLEOTIDE POLYMORPHISM"; U.S. Patent Application Publication No. 20090068643 by Behlke and Walder, entitled "DUAL FUNCTION PRIMERS FOR AMPLIFYING DNA AND METHODS OF USE"; U.S. Patent Application Publication No. 20090068643 by Behlke and Walder, entitled "RNASE H-BASED ASSAYS UTILIZING MODIFIED RNA CLEAVE GENERATION"; and U.S. Pat. No. 20100167353 by Walder et al., entitled "MONOMERS"; and Dobosy et al., "RNase H-dependent PCR (rhPCR): improved specificity and single nucleotide polymorphism detection using blocked cleavable primers," BMC Biotechnology., 11:e80 (2011).

[0174] In AS-PCR, the SNP is located at the 3' end of the primer. In this configuration, a mispriming event (DNA synthesis is initiated in the presence of a mismatch at the 3' end) results in the incorporation of the base present in the primer into the nascent DNA strand and thus into the PCR amplicon. This event converts the PCR product into the primer sequence, so that the amplified DNA now matches the primer and no longer matches the nucleic acid sequence of the originally input sample. Since the amplicon sequence now matches the primer and does not match the input sample, amplification proceeds with high efficiency.

[0175] In rhPCR, cleavage of the blocked cleavable primer by RNase H2 occurs at the 5' side of the RNA residue; if the SNP is located at the RNA residue (e.g., an RNA base pair with a SNP), the first base incorporated by DNA polymerase and PCR during primer extension is at the SNP site, resulting in a daughter product that remains identical to the input nucleic acid sequence. Rarely, non-standard RNase H2 cleavage occurs at the 3' side of the RNA base leaving an RNA residue at the 3' end of the primer positioned to cover the SNP. In this case, the rhPCR reaction proceeds like AS-PCR, with the 3' end of the primer located at the SNP site and either a match or a mismatch to the target nucleic acid. As with AS-PCR, in the case of a mismatch, the sequence of the DNA extension product and the PCR amplicon may convert to the sequence of the primer and thus not faithfully replicate the sequence of the sample being amplified. Any method that reduces the frequency of this undesired mispriming event improves mismatch discrimination in rhPCR assays. Thus, although base discrimination in rhPCR is primarily mediated by RNase H2 at the primer cleavage step, the use of a DNA polymerase with improved ability to discriminate against 3'-terminal mismatches and / or 3'-terminal RNA residues may improve the overall mismatch discrimination ability of rhPCR by preventing extension when undesired 3'-cleavage events occur. The DNA polymerase mutants described herein reduce priming efficiency when a 3'-mismatch is present (improves mismatch discrimination) and reduce priming efficiency when a 3'-terminal RNA residue is present in the primer (discriminates against primer 3'-RNA residues) compared to wild-type Taq DNA polymerase. This example demonstrates that the novel mutant Taq DNA polymerases of the present invention improve the specificity and SNP discrimination of rhPCR.

[0176] Quantitative real-time rhPCR was performed comparing the performance of wild-type OptiTaq DNA polymerase with mutant Taq DNA polymerase mutants ID2, 3, 10 and 18. Two different blocked-cleavable primer designs were tested, including a generation 1 (Gen1) "RDDDDx" primer and a generation 2 (Gen2) "RDxxD" primer (see US Patent Application Publication No. 2012 / 0258455 by Behlke et al., entitled "RNASE H-BASED ASSAYS UTILIZING MODIFIED RNA MONOMERS"). Amplification reactions were performed using the same synthetic oligonucleotide templates employed in Example 5, where a single base was altered (SNP site) located to position an RNA residue in both the Gen1 and Gen2 blocked-cleavable (rhPCR) primers. Synthetic templates with each of the four possible bases at this position were employed. Reverse primers with each of the four possible complementary bases at this position were employed (RNA base). The same forward primer was used for all reactions. The relative amplification efficiency was assessed using real-time PCR.

[0177] Quantitative rhPCR is 2 x 10 6The experiments were carried out in 10 μL reaction volumes in a 384-well format using a 103 bp synthetic template (SEQ ID NO:51-54) of 10 copies. The final reaction conditions used were 20 mM Tris-HCL (pH 8.4 at 25° C.), 50 mM KCL, 3 mM MgCl2, 0.01% Triton X-100, 800 μM total dNTPs, 200 nM universal forward primer (SEQ ID NO:60), 200 nM reverse primer, and 200 nM 5′ nuclease detection probe (SEQ ID NO:61). Reverse primers included allele-specific rhPCR primers in Gen1 RDDDDx configuration (SEQ ID NO:66-69), allele-specific rhPCR primers in Gen2 RDxxD configuration (SEQ ID NO:70-73), and a control universal reverse primer (SEQ ID NO:59). Each of the rhPCR blocked-cleavable reverse primers was tested for each of the four SNP templates. Reactions utilized either 0.5U (10.8ng / 11.1nM / 111fmol) of wild-type OptiTaq DNA polymerase or 0.5U of one of four Taq DNA polymerase mutants (MUT ID2 V783F; MUT ID3 H784Q; MUT ID10, A661E I665W F667L; or MUT ID18, V783L H784Q). P. abyssi RNase H2 was added to each reaction in a 1μL volume. Reactions using control and Gen1 blocked-cleavable RDDDDx rhPCR primers employed 2.6mU RNase H2 / 10μL reaction (5fmole, 0.5nM enzyme). Reactions using Gen2 blocked-cleavable RDxxD rhPCR primers employed 25 mM RNase H2 / 10 μL reaction (48 fmole, 4.8 nM enzyme) for rC and rA primers (SEQ ID NOs: 71 and 72) and 200 mU RNase H2 / 10 μL reaction (384 fmole, 38 nM enzyme) for rG and rU primers (SEQ ID NOs: 70 and 73).Cycling was performed on a Roche LightCycler® 480 (Roche Applied Science, Indianapolis, IN, USA) as follows: 95° C. for 3 min, followed by 75 cycles of 95° C. for 10 s and 60° C. for 30 s. All reactions were performed in triplicate. The oligonucleotide reagents used in this example are shown in Table 14.

[0178] [Table 14]

[0179] MUT ID10 (A661E, I665W, F667L) unexpectedly showed a large amplification delay when the primer matched the SNP site in the target in the rhPCR reaction using this synthetic amplicon system. However, this polymerase did not show any delay when using the human genomic DNA system for rhPCR (see Examples 8 and 9). Therefore, MUT ID10 was excluded from the analysis in the synthetic system experiment. Data generated using the other three mutant polymerases was analyzed and ΔCq values ​​were calculated compared to matched vs. mismatched primer / template pairs. In this case, ΔCq=Cqmismatch-Cqmatch. The results are shown in Table 15 for Gen1 RDDDDx blocked cleavable primer rhPCR primers and Table 16 for Gen2 RDxxD blocked cleavable primer rhPCR primers.

[0180] [Table 15] TIFF0007640606000026.tif79166

[0181] [Table 16] TIFF0007640606000028.tif80165

[0182] In almost all cases, mismatch discrimination was superior for rhPCR reactions performed using mutant Taq DNA polymerases compared to wild-type OptiTaq. The magnitude of improvement is best seen by examining the ΔΔCq values, which is the difference in discrimination seen using wild-type OptiTaq and the mutant (ΔΔCq=ΔCq mutant-ΔCq wild-type). These results are shown in Table 17 for Gen1 RDDDDx primers and Table 18 for Gen2 RDxxD primers. When using Gen1 RDDDDx primers, the greatest overall benefit was seen when the mismatched base was a "C" in the target nucleic acid, and the smallest benefit was seen when the blocked-cleavable primer contained an rG paired with a mismatched T in the target. The greatest improvement was obtained using mutant Taq DNA polymerase MUT ID18(V783L H784Q). The average ΔΔCq for MUT ID2(V783F) was 1.0. The average ΔΔCq for MUT ID3(H784Q) was 2.0. The average ΔΔCq for MUT ID18(V783L, H784Q) was 3.6. The benefit obtained using mutant Taq DNA polymerase was lower than for Gen2 RDxxD primers, which already showed high ΔCq values ​​using wild-type OptiTaq. The average ΔΔCq for the three mutant polymerases studied in the examples was 0.6, 2.1 and 1.2. Thus, the greatest benefit when using Gen2 RDxxD primers was seen with MUT ID3(H784Q).

[0183] [Table 17]

[0184] [Table 18]

[0185] [Example 8] Improved mismatch discrimination in rhPCR using mutant Taq DNA polymerase in human genomic DNA SNP assays Example 7 demonstrated the utility of the novel mutant Taq DNA polymerase of the present invention in a synthetic amplicon rhPCR SNP discrimination assay system. This example demonstrated the utility of the novel mutant Taq DNA polymerase in a human genomic DNA rhPCR SNP discrimination assay system to investigate the SNP site in the SMAD7 gene (NM_005904, C / T SNP, rs4939827). The assay employed target DNA GM18562 (homozygous C / C) and GM18537 (homozygous T / T) from the Coriell Institute for Medical Research (Camden, NJ, USA). Two different blocked-cleavable primer designs were tested, including generation 1 (Gen1) "RDDDDx" primers and generation 2 (Gen2) "RDxxD" primers (see U.S. Patent Application No. 2012 / 0258455 by Behlke et al., entitled "RNASE H-BASED ASSAYS UTILIZING MODIFIED RNA MONOMERS").

[0186] Quantitative real-time rhPCR was performed in 10 μL reaction volumes in a 384-well format containing 20 ng (corresponding to 6600 copies of target) of human genomic DNA (GM18562 or GM18537). Reactions utilized either 0.5 U (10.8 ng / 11.1 nM / 111 fmol) of wild-type OptiTaq DNA polymerase or 0.5 U of one of four Taq DNA polymerase mutants (MUT ID2, V783F; MUT ID3, H784Q; MUT ID10, A661E I665W F667L; or MUT ID18, V783L H784Q). The final reaction conditions used were 20 mM Tris-HCL (pH 8.4 at 25° C.), 50 mM KCL, 3 mM MgCl2, 0.01% Triton X-100, 800 μM total dNTPs, 200 nM forward primer (SEQ ID NO: 75-79), 200 nM universal reverse primer (SEQ ID NO: 74) and 200 nM SMAD7 probe (SEQ ID NO: 80). The sequence of the 85 bp SMAD7 amplicon is shown as SEQ ID NO: 81. Forward primers included RDDDDx-configured Gen1 allele-specific rhPCR primers (SEQ ID NO: 76 and 77), RDxxD-configured Gen2 allele-specific rhPCR primers (SEQ ID NO: 78 and 79), and a non-allele specific control universal forward primer (SEQ ID NO: 75). The oligonucleotide reagents employed in this example are shown in Table 19. Reactions contained 1 μL of PaRNase H2 at a concentration of 2.6 mU (5 fmole, 0.5 nM) per 10 μL reaction for Gen1 RDDDDx and control primers (SEQ ID NOs: 75-77) or 200 mU (384 fmole, 38.4 nM) per 10 μL reaction for Gen2 RDxxD primers (SEQ ID NOs: 78 and 79). Amplifications were performed on a Roche LightCycler® 480 (Roche Applied Science, Indianapolis, IN, USA) as follows: 95° C. for 3 min, followed by 75 cycles of 95° C. for 10 s and 60° C. for 30 s. All reactions were performed in triplicate.

[0187] [Table 19] TIFF0007640606000032.tif81162

[0188] Results using Gen1 RDDDDx rhPCR primers are shown in Table 20, and results using Gen2 RDxxD rhPCR primers are shown in Table 21. Overall, the use of mutant Taq DNA polymerase showed a small but real improvement in SNP discrimination in this human genomic DNA rhPCR assay using Gen1 RDDDDx primers. However, a larger improvement in discrimination was seen using Gen2 RDxxD primers. Gen2 RDxxD primers showed substantially greater SNP discrimination, and these levels increased such that ΔCq values ​​were in some cases greater than 40 amplification cycles between match and mismatch; this level of discrimination will be "greater than the assay" for most users, since qPCR reactions rarely went beyond 45-50 cycles and positive signals were not detected in these cases until after 70 cycles (Table 21). Thus, the use of novel mutant Taq DNA polymerases improves SNP discrimination in rhPCR genotyping assays.

[0189] [Table 20] TIFF0007640606000034.tif49165

[0190] [Table 21] TIFF0007640606000036.tif48164

[0191] The ΔCq values ​​for the SMAD7 SNP genotyping assays are graphically summarized in FIG. 5A for the Gen1 RDDDDx primers and in FIG. 6A for the Gen2 RDxxD primers. It is interesting to note that for the rhPCR genotyping assays studied in Example 8, MUT ID10 (A661E I665W F667L) showed the greatest improvement compared to wild-type OptiTaq, especially when using the Gen2 RDxxD primers. Example 5 demonstrates the utility of mutant Taq DNA polymerases in AS-PCR, in which the use of MUT ID18 (V783L H784Q) showed the greatest benefit, and MUT ID3 (H784Q) showed the next greatest relative benefit. It is clear that not only do the various mutant Taq DNA polymerases of the present invention have utility in different amplification assays, but also that different mutants show various levels of benefit depending on the nature of the assay used. It is therefore beneficial to have a collection of mutant polymerases whose properties can be matched to different assays / applications so that maximum benefit is obtained.

[0192] [Example 9] Improved discrimination of low-frequency alleles in genomic DNA using rhPCR with mutant Taq DNA polymerase. The use of Gen2 RDxxD blocked-cleavable primers in rhPCR can detect the presence of SNPs at levels of 1:1,000 to 1:10,000 in a background of wild-type genomic DNA using native (wild-type) Taq DNA polymerase (see U.S. Patent Application No. 2012 / 0258455 by Behlke et al., entitled "RNASE H-BASED ASSAYS UTILIZING MODIFIED RNA MONOMERS.") This example demonstrates that mutant Taq DNA polymerases of the invention improve low frequency allele discrimination in rhPCR assays.

[0193] Low-frequency allele detection experiments were designed to detect the base identity of the SNP site in the SMAD7 gene (NM_005904, C / T SNP, rs4939827) and employed target DNA GM18562 (homozygous C / C) and GM18537 (homozygous T / T) (Coriell Medical Institute, Camden, NJ, USA). Control reactions were set up using matched target DNA with input of 2ng (660 copies), 0.2ng (66 copies) or 0.02ng (6.6 copies). Low-frequency allele detection reactions were set up using matched target DNA with input of 2ng (660 copies), 0.2ng (66 copies) or 0.02ng (6.6 copies) of one allele plus 200ng (66,000 copies) of the other (mismatched) gene. Background was established in reactions that contained 0 copies of matched target DNA + 200 ng (66,000 copies) of mismatched target DNA. Both combinations were tested: GM18562 (C / C) as the low frequency allele in the presence of excess GM18537 (T / T) and GM18537 (T / T) as the low frequency allele in the presence of excess GM18562 (C / C).

[0194] Quantitative real-time rhPCR was performed in a 10 μL reaction volume in a 384-well format. The final reaction conditions used were 10 mM Tris-HCL (pH 8.4 at 25° C.), 50 mM KCL, 3.5 mM MgCl2, 0.01% Triton X-100, 0.8 mM dNTPs, 200 nM of one of the SMAD7 forward primers (SEQ ID NO: 75, 78 and 79), 200 nM of the SMAD7 reverse primer (SEQ ID NO: 74) and 200 nM of the SMAD7 probe (SEQ ID NO: 80). The 85 bp SMAD7 amplicon defined by these primers is shown as SEQ ID NO: 81. Note that the forward primer was either unmodified (control, SEQ ID NO: 75) or specific for the SMAD7 C-allele (SEQ ID NO: 78) or the SMAD7 T-allele (SEQ ID NO: 79) using the blocked-cleavable rhPCR Gen2 RDxxD design. Reactions utilized either 0.5U of wild-type OptiTaq DNA polymerase or 0.5U of one of the four Taq DNA polymerase mutants studied (MUT ID No. 2, V783F; MUT ID No. 3, H784Q; MUT ID No. 10, A661E I665W F667L; or MUT ID No. 18, V783L H784Q). Reactions contained P. abyssi RNase H2 at a concentration of 200mU (384fmole) per 10μL reaction when SMAD7 For rC DxxD (SEQ ID NO: 78) primers were used and P. abyssi RNase H2 at a concentration of 500-600mU (960-1152fmole) per 10μL reaction when control reactions or SMAD7 For rU DxxD (SEQ ID NO: 79) primers were used. The oligonucleotide reagents used in this example are shown in Table 22. Cycling was performed on a Roche LightCycler® 480 (Roche Applied Science, Indianapolis, IN, USA) as follows: 95° C. for 3 min, followed by 65 cycles of 95° C. for 10 s and 60° C. for 30 s. All reactions were performed in triplicate.

[0195] [Table 22] TIFF0007640606000038.tif50161

[0196] The results were analyzed and are shown in Table 23. The control column shows the Cq values ​​for matched primer / target reactions, with no mismatched target present, establishing a quantitative standard curve. The low frequency allele detection column shows the Cq values ​​for detection of 660, 66, 6 or 0 (background control) copies of matched primer / target in the presence of 66,000 copies of mismatched target. At least a 3 cycle difference between background and positive signal (ΔCq=3.0 or more) is required to call a reaction "positive" for low frequency allele detection; it is generally assumed that a 5 cycle difference (ΔCq=5.0 or more) is preferred. In this system, background is the signal observed when amplification is performed using a non-input target that matches the primer, so the signal only comes from amplification originating from the mismatched target.

[0197] Using wild-type OptiTaq DNA polymerase, both detection of the "C" allele in an excess of "T" background and detection of the "T" allele in an excess of "C" background met the ΔCq3.0 and ΔCq5.0 levels of stringency to call a 1:1000 low-frequency allele detection event (66 copies of match target in the presence of 66,000 copies of mismatch target). The 1:10,000 reaction (6 copies of match target in the presence of 66,000 copies of mismatch target) did not meet either of these criteria. Thus, rhPCR had a 1:1000 low-frequency allele detection limit using wild-type OptiTaq in this genomic DNA SNP system.

[0198] In contrast, rhPCR using each of the four mutants showed a low-frequency allele detection limit of 1:10,000 for both the "C" and "T" allele targets with a ΔCq stringency cutoff of 3.0. MUT ID3(H784Q) showed a low-frequency allele detection limit of 1:10,000 for both the "C" and "T" targets in this genomic SNP system for a higher ΔCq stringency cutoff of 5.0. Three other mutant Taq DNA polymerases (MUT ID No. 2, V783F; MUT ID No. 10, A661E I665W F667L; and MUT ID No. 18, V783L H784Q) showed a low-frequency allele detection limit of 1:10,000 for the "C" allele target with a ΔCq stringency cutoff of 5.0, and a low-frequency allele detection limit of 1:10,000 for the "T" allele target with a ΔCq stringency cutoff of 3.0. Thus, we conclude that the novel mutant Taq DNA polymerases of the present invention provide improved low-frequency allele detection reactions using blocked-cleavable primers in rhPCR compared to the use of wild-type DNA polymerases.

[0199] [Table 23] TIFF0007640606000040.tif240156

[0200] [Example 10] Sequences of Taq DNA polymerase mutants that exhibit improved discrimination against mismatches or the presence of an RNA residue at the 3' end of the primer. The complete amino acid and nucleotide sequences of the codon-optimized mutant enzymes employed in Examples 5-9 are shown below. These sequences can be readily derived by one of skill in the art from the information provided in Tables 1, 3, 4 and 5, but for clarity, the final assembled sequences are provided. Base changes are identified in bold underlined font for nucleic acid and amino acid substitutions.

[0201] SEQ ID NO:82, nucleotide sequence of mutant ID2(V783F).

[0202] [ka]

[0203] SEQ ID NO: 83, amino acid sequence of mutant ID2(V783F).

[0204] [ka]

[0205] SEQ ID NO: 84, nucleotide sequence of mutant ID3(H784Q).

[0206] [ka]

[0207] SEQ ID NO: 85, amino acid sequence of mutant ID3(H784Q).

[0208] [ka]

[0209] SEQ ID NO: 86, nucleotide sequence of mutant ID10 (A661E, I665W, F667L).

[0210] [ka]

[0211] SEQ ID NO: 87, amino acid sequence of mutant ID10 (A661E, I665W, F667L).

[0212] [ka]

[0213] SEQ ID NO: 88, nucleotide sequence of mutant ID18 (V783L, H784Q).

[0214] [ka]

[0215] SEQ ID NO: 89, amino acid sequence of mutant ID18 (V783L, H784Q).

[0216] [ka]

[0217] [Example 11] BLAST search for additional wild-type VH-related DNA polymerases A BLAST search using the Taq DNA polymerase sequence G755 across P812 (SEQ ID NO: 90) as a comparison window was performed using online databases available through the National Center for Biotechnology Information in the National Library of Medicine at the National Institutes of Health (http: / / www.ncbi.nlm.nih.gov / ). The BLAST search revealed numerous wild-type DNA polymerases from other species that share extensive sequence identity with Taq DNA polymerase, including identity at positions V783 and H784 of Taq DNA polymerase ("VH-related DNA polymerases"). An exemplary list of these thermostable polymerases is shown in Table 24, and a similar list of putative thermosensitive polymerases is shown in Table 25. In all identified wild-type polymerase genes except one (Fachramia hominis), the amino acids corresponding to V783 and H784 of Taq DNA polymerase were conserved. However, in an exceptional case, namely that of Fachremia hominis, Ile naturally occurs at the residue position of Taq DNA polymerase corresponding to V783. However, Taq DNA polymerase variants corresponding to mutant ID1 containing this particular substitution behave like wild-type Taq DNA polymerase. Thus, it is assumed that Fachremia hominis DNA polymerase seemingly results from a strong selection for Val at this position and maintains wild-type activity when either Val or Ile residues are present. These BLAST results confirm the natural counterselection against DNA polymerases with increased template discrimination activity and provide strong evidence that the disclosed engineered Taq DNA polymerase mutants with these properties are novel and nonobvious.

[0218] These identified DNA polymerases share extensive sequence homology with Taq DNA polymerase in the region including residues V783 and V784 of Taq DNA polymerase. As observed with engineered Taq DNA polymerase mutants, each of the identified non-Taq DNA polymerases represents a sequence space in which engineered mutant enzymes with increased template discrimination activity compared to their respective unmodified counterparts may arise. The magnitude of increased template discrimination activity obtained for the same amino acid substitution for a non-Taq DNA polymerase may not be the same as compared to the respective unmodified non-Taq DNA polymerase, or even compared to the magnitude of increased template discrimination activity observed for the corresponding Taq DNA polymerase mutant. Nevertheless, a strong prediction of this disclosure is that at least some amino acid substitutions in non-Taq DNA polymerases with homology to residues V783 and / or H784 of Taq DNA polymerase will exhibit increased template discrimination activity compared to their respective unmodified counterparts.

[0219] [Table 24] TIFF0007640606000050.tif234159

[0220] [Table 25]

[0221] [Example 12] Generation of additional codon-optimized Taq DNA polymerase mutants at position H784 After characterizing the first 18 mutant versions of Taq polymerase (Table 3, Mut ID1-18), an additional 18 mutant versions of Taq DNA polymerase (Table 3, Mut ID19-30) were generated by site-directed mutagenesis of the cloned OptiTaq codon-optimized WT Taq DNA polymerase. The complete set represents all possible amino acid changes at position 784 in Taq polymerase. Specific mutations were introduced into the OptiTaq sequence using PCR site-directed mutagenesis (Weiner MP et al., Gene., 151(1-2):119-23 (1994)). Each mutagenesis reaction employed 10 pmol of two complementary oligonucleotides (Table 26) containing the desired base changes annealed to double-stranded OptiTaq plasmid (20 ng), 5 U KOD DNA polymerase (Novagen-EMD Chemicals, San Diego, CA), 1.5 mM MgSO4 in 1× KOD PCR buffer. Thermal cycling parameters were 16 cycles of 95°C for 3 min (95°C for 20 s-55°C for 20 s-70°C for 2.5 min), followed by a 4 min soak at 70°C. After PCR site-directed mutagenesis, the amplified products were treated with 10 U of DpnI (NEB, Ipswish, MA) for 1 h at 37°C, followed by inactivation at 80°C for 20 min. One-hundredth of the digested material was transformed into XL-1 Blue competent bacteria. Bacterial clones were isolated, plasmid DNA was prepared, and individual mutations were confirmed by Sanger DNA sequencing. All mutants were carried in the pET-27b(+) expression vector suitable for expressing recombinant proteins in E. coli. Expression and purification of the recombinant mutants of Taq polymerase was carried out as described in Example 3.

[0222] [Table 26] TIFF0007640606000053.tif213170TIFF0007640606000054.tif74170

[0223] [Example 13] Characterization of the properties of 18 mutant Taq DNA polymerases altered at position H784 in PCR. The 18 mutant Taq DNA polymerase enzymes described in Example 12 were characterized for polymerase activity and ability to discriminate between 3'-RNA residues in primer oligonucleotides.

[0224] The unit activity of purified wild-type protein was determined by comparing the performance in qPCR of known amounts of OptiTaq and each mutant compared to a commercially available native non-hot-start Taq DNA polymerase, Taq-B DNA polymerase (Enzymatics, Beverly, MA). Quantitation cycle values ​​(Cq, the amplification cycle number at which a positive signal is first detected) and amplification curve shapes were analyzed to determine the nanogram amounts at which both enzymes performed similarly within the suboptimal range for each. Using these nanogram amounts and the known unit values ​​for Taq-B DNA polymerase, relative activity unit values ​​could be extrapolated for all of the mutant DNA polymerase enzymes that had sufficient activity to support PCR.

[0225] The following reaction conditions were employed: 1x qPCR buffer (20 mM Tris pH 8.4, 50 mM KCl, 3 mM MgCl, 0.01% Triton-X100), 800 µM dNTPs (200 µM each), 500 nM For primer (Hs HPRT F517, SEQ ID NO: 43), 500 nM Rev primer (Hs HPRT R591, SEQ ID NO: 44), 250 nM probe (Hs HPRT P554, SEQ ID NO: 45), 2x10 3copy linear cloned plasmid template (HPRT-targ, SEQ ID NO: 46). The amount of DNA polymerase added to each reaction was varied as follows: for wild type (OptiTaq), reactions were set up using 10, 1, 0.1, 0.01, 0.001 U / μL (220, 22, 2.2, 0.22 or 0.022 ng of protein per 10 μL reaction). Mutant polymerases were run at similar concentrations. Those mutant enzymes showing polymerase activity were also titrated more finely, testing 220, 22, 10.6, 4.8, 2.2, 1.1, 0.48 and 0.22 ng of protein per 10 μL reaction. Enzyme dilutions were made in enzyme dilution buffer (20 mM Tris pH 7.5, 100 mM NaCl, 1 mM DTT, 0.1% Triton-X100, 1 mg / mL BSA, 10% glycerol). Reactions were performed in 384-well format on a BIO-RAD CFX384™ Real-Time System (BIO-RAD, Hercules, CA) using the following cycling parameters: 95° C. for 30 seconds, followed by 60 cycles of [95° C. for 15 seconds, followed by 60° C. for 1 minute]. Detection was achieved using a fluorescence quenched probe (5'-nuclease assay format; note that the mutations introduced in this series of Taq mutants are not in the 5'-nuclease domain). The sequences of primers, probes and templates (plasmid inserts) are shown in Table 27.

[0226] [Table 27]

[0227] These 18 Taq DNA polymerase mutants were characterized as outlined above. The results are summarized in Table 28. Ten mutants, including mutants ID19, 23, 25, 28, and 31 to 36, did not show detectable DNA polymerase activity and were not studied further. Four mutants, mutants ID20, 21, 27, and 29, had DNA polymerase activity; however, the processivity was reduced 4-6 fold compared to the wild-type enzyme. Three mutants, mutants ID24, 26, and 30, showed DNA polymerase activity similar to wild-type OptiTaq.

[0228] [Table 28]

[0229] A subset of these mutant Taq DNA polymerases that showed adequate levels of DNA polymerase activity were studied for their ability to discriminate between primers bearing 3'-DNA versus 3'-RNA residues, in comparison to the wild-type OptiTaq enzyme. Real-time PCR was performed as previously described, employing in the reaction an amount of each mutant DNA polymerase equivalent to 0.5 units of wild-type OptiTaq per 10 μL reaction. The following reaction conditions were employed: 1x qPCR buffer (20 mM Tris pH 8.4, 50 mM KCl, 3 mM MgCl2, 0.01% Triton-X100), 800 µM dNTPs (200 µM each), 500 nM For primer (Hs SFRS9 F569rU, SEQ ID NO: 47), 500 nM Rev primer (Hs SFRS9 R712 rA, SEQ ID NO: 48), 250 nM probe (Hs SFRS9 P644, SEQ ID NO: 49), 2x10 3Copy linear cloned plasmid template (SFRS9-targ, SEQ ID NO:50). Reactions were performed in 384-well format on a BIO-RAD CFX384™ Real-Time System (BIO-RAD, Hercules, CA) using the following cycling parameters: 95° C. for 30 seconds, followed by 60 cycles of [95° C. for 15 seconds, followed by 60° C. for 1 minute]. Detection was achieved using a fluorescently quenched probe (5'-nuclease assay format). Primer, probe and template (plasmid insert) sequences are shown in Table 29.

[0230] [Table 29]

[0231] Eight Taq DNA polymerase mutants that supported PCR were tested for their ability to use 3'-RNA modified primers as outlined above. The results are summarized in Table 28. Mutants ID20 and 22 showed no difference between primers with 3'-DNA compared to 3'-RNA residues. Mutants ID21, 24, 26, 27, 29 and 30 showed amplification retardation using 3'-RNA primers. Thus, additional Taq DNA polymerase mutants were identified and differentiated for priming from 3'-RNA residues. Those mutants that showed some retardation with RNA priming and showed high processivity were studied for improvement in primer 3'-residue mismatch discrimination.

[0232] [Example 14] Improved mismatch discrimination in allele-specific PCR using mutant Taq DNA polymerase altered at position H784. Of the 18 mutant enzymes studied in Examples 12 and 13, mutants ID21, 24, 26, 27, 29 and 30 showed the ability to discriminate 3'-RNA residues in the primer and retained high enzyme activity / processivity. These six mutants and additionally mutants ID20 and 22 were studied for their ability to discriminate 3'-terminal DNA mismatches compared to wild-type OptiTaq DNA polymerase using an allele-specific qPCR assay. Amplification reactions were performed on synthetic oligonucleotide templates, in this case with a single base change (SNP) placed at the 3' end of the reverse primer. Synthetic templates with each of the four possible bases at this position were employed. Reverse primers with each of the four possible bases at the 3' end were employed. The relative amplification efficiency of all pairs of primer / template combinations was assessed using qPCR.

[0233] Quantitative allele-specific real-time PCR (AS-qPCR) yielded 2 × 10 5The reaction was carried out in a 10 μL reaction volume in a 384-well format using a 103 bp synthetic template (SEQ ID NO:51-54) of copies. The final reaction conditions used were 20 mM Tris-HCL (pH 8.4 at 25° C.), 50 mM KCL, and 3 mM MgCl2, 0.01% Triton X-100, 800 μM total dNTPs, as well as 200 nM of the universal forward primer (SEQ ID NO:60), 200 nM of the reverse primer (separate reactions were set up for each of the allele-specific primers SEQ ID NO:55-58 or the control universal primer SEQ ID NO:59), and 200 nM of the 5′ nuclease detection probe (SEQ ID NO:61). Each allele-specific primer was tested on each SNP template. Reactions were incubated with 0.5 U (10.8 ng / 11.1 nM / 111 fmol) of wild-type OptiTaq DNA polymerase or 0.5 U of the nine Taq DNA polymerase mutants studied (mutant ID3 (H784Q) (10.8 ng / 11.1 nM / 111 fmol); mutant ID20 H784A (54 ng / 55.5 nM / 555 fmol); mutant ID22 H784T (10.8 ng / 11.1 nM / 111 fmol); mutant ID24 H784V (24 ng / 24.7 nM / 246.7 fmol); mutant ID26 H784I (21.6 ng / 22.2 nM / 222 fmol); mutant ID27 H784M (10.8 ng / 11.1 nM / 111 fmol); mutant ID29 Either H784F (49.1 ng / 49.4 nM / 494.5 fmol); mutant ID30 H784Y) (24 ng / 24.7 nM / 246.7 fmol) were utilized. Amplification was performed on a CFX384™ C1000™ Thermocycler System (Bio-Rad, Hercules, Calif.) using the following cycling parameters: initial denaturation at 95° C. for 30 seconds, followed by 60 cycles of 95° C. for 10 seconds, followed by 60 cycles of 60° C. for 30 seconds. The oligonucleotide reagents used in this example are shown in Table 30.

[0234] [Table 30]

[0235] Initially, all reactions were performed in triplicate. Similar results were obtained for all replicates when wild-type OptiTaq was used. However, the results showed a greater variation for the mutant polymerase. Therefore, to obtain statistically meaningful results, each reaction was performed 24 times for the mutant polymerase and 21 times for the wild-type enzyme. ΔCq values ​​were calculated as the Cq value obtained for each mismatched base pair minus the Cq value obtained for the matched base pair (ΔCq=Cqmismatch-Cqmatch). The ΔCq values ​​for all 24 replicates were averaged and the standard deviation was calculated. The results are shown in Table 31 and summarized graphically in Figures 3C, 3D, 3D, 3F and 3G. Note that the reverse primer is an allele-specific primer. Therefore, the "Syn Rev T" primer (SEQ ID NO:55) is a perfect match for template A (SEQ ID NO:51), and so on.

[0236] [Table 31] TIFF0007640606000060.tif225167TIFF0007640606000061.tif235166TIFF0007640606000062.tif82165

[0237] Wild-type OptiTaq showed an average ΔCq for AS-qPCR in this synthetic amplicon system of 4.1 with a range of -0.8 to 8.5. Mutant ID3 (H784Q) showed an average ΔCq of 9.9 with a range of 4.6 to 21.2. Mutant ID20 (H784A) showed an average ΔCq of 11.2 with a range of 6.3 to 14.9. Mutant ID21 (H784S) showed an average ΔCq of 15.3 with a range of 6.6 to 25.8. Mutant ID22 (H784T) showed an average ΔCq of 6.6 with a range of 1.5 to 13.3. Mutant ID24 (H784V) showed an average ΔCq of 4.1 with a range of -0.3 to 10.2. Mutant ID26 (H784I) showed an average ΔCq of 5.0 with a range of 0.3 to 11.3. Mutant ID27 (H784M) showed an average ΔCq of 9.8 with a range of 4.5 to 16.7. Mutant ID29 (H784F) showed an average ΔCq of 7.8 with a range of 3.5 to 13.3. Mutant ID30 (H784Y) showed an average ΔCq of 8.3 with a range of 5.3 to 15.7. Thus, in almost all pairwise combinations of the four template bases and the four 3'-end primer bases, the mutant Taq DNA polymerase of the present invention showed greater discrimination against mismatches than the wild-type OptiTaq DNA polymerase. The magnitude of improvement for each mismatch pair is defined by the ΔΔCq, which is the difference in discrimination between the mutant and wild-type enzymes (ΔΔCq = ΔCq mutant - ΔCq wild-type). ΔΔCq values ​​were calculated and are shown in Table 32.

[0238] [Table 32] TIFF0007640606000064.tif234167TIFF0007640606000065.tif234166TIFF0007640606000066.tif69166

[0239] Mutant ID3 (H784Q) showed a mean ΔΔCq of 4.9 compared to wild-type OptiTaq. Mutant ID20 (H784A) showed a mean ΔΔCq of 7.1 compared to wild-type OptiTaq. Mutant ID21 (H784S) showed a mean ΔΔCq of 11.2 compared to wild-type OptiTaq. Mutant ID22 (H784T) showed a mean ΔΔCq of 2.5 compared to wild-type OptiTaq. Mutant ID24 (H784V) showed a mean ΔΔCq of -0.2 compared to wild-type OptiTaq. Mutant ID26 (H784I) showed a mean ΔΔCq of 1.0 compared to wild-type OptiTaq. Mutant ID27 (H784M) showed a mean ΔΔCq of 5.7 compared to wild-type OptiTaq. Mutant ID29 (H784F) showed an average ΔΔCq of 3.6 compared to wild-type OptiTaq. Mutant ID30 (H784Y) showed an average ΔΔCq of 4.2 compared to wild-type OptiTaq. Thus, with the exception of mutant ID24 (H784V), each of the mutant Taq DNA polymerases of the invention showed significant improvement in mismatch discrimination compared to wild-type OptiTaq. Overall, mutant ID21 (H784S) showed the best SNP discrimination within the set of nine mutant enzymes studied in this example using the AS-PCR assay.

[0240] [Example 15] Improved mismatch discrimination in rhPCR using mutant Taq DNA polymerase in human genomic DNA SNP assays Example 14 demonstrated the utility of the novel mutant Taq DNA polymerase of the present invention in a synthetic amplicon rhPCR SNP discrimination assay system. This example demonstrated the utility of the novel mutant Taq DNA polymerase in a human genomic DNA rhPCR SNP discrimination assay system to investigate the SNP site in the SMAD7 gene (NM_005904, C / T SNP, rs4939827). The assay employed target DNA GM18562 (homozygous C / C) and GM18537 (homozygous T / T) from the Coriell Institute for Medical Research (Camden, NJ, USA). Two different blocked-cleavable primer designs were tested, including generation 1 (Gen1) "RDDDDx" primers and generation 2 (Gen2) "RDxxD" primers (see U.S. Patent Application No. 2012 / 0258455 by Behlke et al., entitled RNASE H-BASED ASSAYS UTILIZING MODIFIED RNA MONOMERS).

[0241] Quantitative real-time rhPCR was performed in a 10 μL reaction volume in a 384-well format containing 20 ng (corresponding to 6600 copies of target) of human genomic DNA (GM18562 or GM18537). Reactions utilized either 0.5 U (10.8 ng / 11.1 nM / 111 fmol) of wild-type OptiTaq DNA polymerase or 0.5 U of one of nine Taq DNA polymerase mutants (MUT ID3, H784Q; MUT ID20, H784A; MUT ID21, H784S; MUT ID22, H784T; MUT ID24, H784V; MUT ID26, H784I; MUT ID27 H784M; MUT ID29, H784F; MUT ID30, H784Y). The final reaction conditions used were 20 mM Tris-HCL (pH 8.4 at 25° C.), 50 mM KCL, 3 mM MgCl2, 0.01% Triton X-100, 800 μM total dNTPs, 200 nM forward primer (SEQ ID NO: 75-79), 200 nM universal reverse primer (SEQ ID NO: 74) and 200 nM SMAD7 probe (SEQ ID NO: 80). The sequence of the 85 bp SMAD7 amplicon is shown as SEQ ID NO: 81. Forward primers included RDDDDx-configured Gen1 allele-specific rhPCR primers (SEQ ID NO: 76 and 77), RDxxD-configured Gen2 allele-specific rhPCR primers (SEQ ID NO: 78 and 79), and a non-allele specific control universal forward primer (SEQ ID NO: 75). The oligonucleotide reagents employed in this example are shown in Table 33. Reactions contained 1 μL of PaRNase H2 at a concentration of 2.6 mU per 10 μL reaction (5 fmole, 0.5 nM) for Gen1 RDDDDx and control primers (SEQ ID NOs: 75-77), except for MUT ID21(H784S), where 200 mU per 10 μL (384 fmole, 38.4 nM) was used, or 200 mU per 10 μL reaction (384 fmole, 38.4 nM) for Gen2 RDxxD primers (SEQ ID NOs: 78 and 79).Amplification was performed on a Roche LightCycler® 480 (Roche Applied Science, Indianapolis, IN, USA) as follows: 95° C. for 3 min, followed by 95 cycles of 95° C. for 10 s and 60° C. for 30 s. All reactions were performed in triplicate.

[0242] [Table 33]

[0243] Results using Gen1 RDDDDx rhPCR primers are shown in Table 34, and results using Gen2 RDxxD rhPCR primers are shown in Table 35. The use of mutant Taq DNA polymerase showed significant improvement in SNP discrimination in this human genomic DNA rhPCR assay using Gen1 RDDDDx primers, but amplification efficiency was often reduced as indicated by the increase in match Cq. A large improvement in discrimination was seen using Gen2 RDxxD primers, but amplification efficiency was often lost here as well. Gen2 RDxxD primers showed substantially greater SNP discrimination, and these levels increased such that ΔCq values ​​were in some cases greater than 40 amplification cycles between match and mismatch; this level of discrimination will be "greater than the assay" for most users, since qPCR reactions rarely went beyond 45-50 cycles and positive signals were not detected in these cases until after 70 cycles (Table 35). Thus, the use of the novel mutant Taq DNA polymerase improves SNP discrimination in rhPCR genotyping assays.

[0244] [Table 34] TIFF0007640606000069.tif226166TIFF0007640606000070.tif16163

[0245] [Table 35] TIFF0007640606000072.tif226167TIFF0007640606000073.tif16163

[0246] The ΔCq values ​​for the SMAD7 SNP genotyping assays are graphically summarized in Figures 5B and 5C for the Gen1 RDDDDx primers and in Figures 6B and 6C for the Gen2 RDxxD primers. It is clear that not only do the various mutant Taq DNA polymerases of the present invention have utility in different amplification assays, but also that different mutants exhibit varying levels of benefit depending on the nature of the assay used. It would therefore be beneficial to have a collection of mutant polymerases whose properties can be matched to different assays / applications so that maximum benefit is obtained.

[0247] [Example 16] Improved discrimination of low-frequency alleles in genomic DNA using rhPCR with mutant Taq DNA polymerase. The use of Gen2 RDxxD blocked-cleavable primers in rhPCR can detect the presence of SNPs at levels of 1:1,000 to 1:10,000 in a background of wild-type genomic DNA using native (wild-type) Taq DNA polymerase (see U.S. Patent Application No. 2012 / 0258455 by Behlke et al., entitled RNASE H-BASED ASSAYS UTILIZING MODIFIED RNA MONOMERS). This example demonstrates that mutant Taq DNA polymerases of the invention improve low frequency allele discrimination in rhPCR assays.

[0248] Low-frequency allele detection experiments were designed to detect the base identity of the SNP site in the SMAD7 gene (NM_005904, C / T SNP, rs4939827) and employed target DNA GM18562 (homozygous C / C) and GM18537 (homozygous T / T) (Coriell Medical Institute, Camden, NJ, USA). Control reactions were set up using matched target DNA with input of 2ng (660 copies), 0.2ng (66 copies) or 0.02ng (6.6 copies). Low-frequency allele detection reactions were set up using matched target DNA with input of 2ng (660 copies), 0.2ng (66 copies) or 0.02ng (6.6 copies) of one allele plus 200ng (66,000 copies) of the other (mismatched) allele. Background was established in reactions that contained 0 copies of matched target DNA + 200 ng (66,000 copies) of mismatched target DNA. Both combinations were tested: GM18562 (C / C) as the low frequency allele in the presence of excess GM18537 (T / T) and GM18537 (T / T) as the low frequency allele in the presence of excess GM18562 (C / C).

[0249] Quantitative real-time rhPCR was performed in a 10 μL reaction volume in a 384-well format. The final reaction conditions used were 10 mM Tris-HCL (pH 8.4 at 25° C.), 50 mM KCL, 3.5 mM MgCl2, 0.01% Triton X-100, 0.8 mM dNTPs, 200 nM of one of the SMAD7 forward primers (SEQ ID NO: 75, 78 and 79), 200 nM of the SMAD7 reverse primer (SEQ ID NO: 74) and 200 nM of the SMAD7 probe (SEQ ID NO: 80). The 85 bp SMAD7 amplicon defined by these primers is shown as SEQ ID NO: 81. Note that the forward primer was either unmodified (control, SEQ ID NO: 75) or specific for the SMAD7 C-allele (SEQ ID NO: 78) or the SMAD7 T-allele (SEQ ID NO: 79) using the blocked-cleavable rhPCR Gen2 RDxxD design. Reactions utilized either 0.5U of wild-type OptiTaq DNA polymerase or 0.5U of one of the three exemplary Taq DNA polymerase mutants studied (MUT ID20 (H784A); MUT ID27 (H784M); MUT ID30 (H784Y)). Reactions contained P. abyssi RNase H2 at a concentration of 200mU (384fmole) per 10μL reaction when SMAD7 For rC DxxD (SEQ ID NO:78) primers were used and P. abyssi RNase H2 at a concentration of 500-600mU (960-1152fmole) per 10μL reaction when control reactions or SMAD7 For rU DxxD (SEQ ID NO:79) primers were used. The oligonucleotide reagents used in this example are shown in Table 36. Cycling was performed on a Roche LightCycler® 480 (Roche Applied Science, Indianapolis, IN, USA) as follows: 95° C. for 3 min, followed by 65 cycles of 95° C. for 10 s and 60° C. for 30 s. All reactions were performed in triplicate.

[0250] [Table 36]

[0251] The results were analyzed and are shown in Table 37. The control column shows the Cq values ​​for matched primer / target reactions, with no mismatched target present, to establish a quantitative standard curve. MUT ID NO.3, H784Q, is included in the data analysis for comparison. The low frequency allele detection column shows the Cq values ​​for detection of 660, 66, 6 or 0 (background control) copies of matched primer / target in the presence of 66,000 copies of mismatched target. At least a 3 cycle difference (ΔCq=3.0 or more) between background and positive signal is required to call a "positive" reaction for low frequency allele detection; it is generally assumed that a 5 cycle difference (ΔCq=5.0 or more) is preferred. In this system, background is the signal observed when amplification is performed using a non-input target that matches the primer, so the signal only comes from amplification originating from the mismatched target.

[0252] Using wild-type OptiTaq DNA polymerase, both detection of the "C" allele in an excess of "T" background and detection of the "T" allele in an excess of "C" background met the ΔCq3.0 and ΔCq5.0 levels of stringency to call a 1:1000 low-frequency allele detection event (66 copies of match target in the presence of 66,000 copies of mismatch target). The 1:10,000 reaction (6 copies of match target in the presence of 66,000 copies of mismatch target) did not meet either of these criteria. Thus, rhPCR had a 1:1000 low-frequency allele detection limit using wild-type OptiTaq in this genomic DNA SNP system.

[0253] In contrast, rhPCR using each of the four mutants showed a low-frequency allele detection limit of 1:10,000 for both "C" and "T" allele targets with a ΔCq stringency cutoff of 3.0. MUT ID3(H784Q) showed a low-frequency allele detection limit of 1:10,000 for both "C" and "T" targets in this genomic SNP system for a higher ΔCq stringency cutoff of 5.0. The other three mutant Taq DNA polymerases (MUT ID20(H784A); MUT ID27(H784M); MUT ID30(H784Y)) showed a low-frequency allele detection limit of 1:10,000 for "C" allele targets with a ΔCq stringency cutoff of 5.0, and a low-frequency allele detection limit of 1:10,000 for "T" allele targets with a ΔCq stringency cutoff of 3.0. Therefore, we conclude that the novel mutant Taq DNA polymerase of the present invention provides an improved low frequency allele detection reaction using blocked-cleavable primers in rhPCR compared to the use of wild-type DNA polymerase.

[0254] [Table 37] TIFF0007640606000076.tif242153

[0255] [Example 17] Sequences of Taq DNA polymerase mutants that exhibit improved discrimination against mismatches or the presence of an RNA residue at the 3' end of the primer. The complete amino acid and nucleotide sequences of the codon-optimized mutant enzymes employed in Examples 11-15 are shown below. These sequences can be readily derived by one of skill in the art from the information provided in Tables 1, 3, 4 and 26, but for clarity, the final assembled sequences are provided. Base changes are identified in bold underlined font for nucleic acid and amino acid substitutions.

[0256] SEQ ID NO: 146, nucleotide sequence of mutant ID20(H784A).

[0257] [ka]

[0258] SEQ ID NO: 147, amino acid sequence of mutant ID20 (H784A).

[0259] [ka]

[0260] SEQ ID NO: 148, nucleotide sequence of mutant ID21(H784S).

[0261] [ka]

[0262] SEQ ID NO: 149, amino acid sequence of mutant ID21(H784S).

[0263] [ka]

[0264] SEQ ID NO: 150, nucleotide sequence of mutant ID22(H784T).

[0265] [ka]

[0266] SEQ ID NO: 151, amino acid sequence of mutant ID22(H784T).

[0267] [ka]

[0268] SEQ ID NO: 152, nucleotide sequence of mutant ID24(H784V).

[0269] [ka]

[0270] SEQ ID NO: 153, amino acid sequence of mutant ID24(H784V).

[0271] [ka]

[0272] SEQ ID NO: 154, nucleotide sequence of mutant ID26(H784I).

[0273] [ka]

[0274] SEQ ID NO: 155, amino acid sequence of mutant ID26(H784I).

[0275] [ka]

[0276] SEQ ID NO: 156, nucleotide sequence of mutant ID27(H784M).

[0277] [ka]

[0278] SEQ ID NO: 157, amino acid sequence of mutant ID27(H784M).

[0279] [ka]

[0280] SEQ ID NO: 158, nucleotide sequence of mutant ID29(H784F).

[0281] [ka]

[0282] SEQ ID NO: 159, amino acid sequence of mutant ID29(H784F).

[0283] [ka]

[0284] SEQ ID NO: 160, nucleotide sequence of mutant ID30(H784Y).

[0285] [ka]

[0286] SEQ ID NO: 161, amino acid sequence of mutant ID30(H784Y).

[0287] [ka]

[0288] [Example 18] Generation of codon-optimized Taq DNA polymerase mutants modified to eliminate 5' exonuclease activity Additional Taq DNA polymerase mutants were generated that eliminated the 5'-exonuclease activity of some of the mutants in Table 3. Taq DNA polymerase lacking 5'-exonuclease activity was previously named "KlenTaq" (Barnes, WM, Gene 112:29-35, 1992). Deletion of the N-terminal 5' exonuclease domain of Taq polymerase improves the mismatch discrimination of the enzyme (Barnes, WM, Gene 112:29-35, 1992). This study characterized whether the specificity improvement seen in the Taq DNA polymerase mutants of the present invention was combined with mutations that eliminated 5'-exonuclease activity. The examples presented herein are intended to illustrate and in no way limit the scope of the claims. Specific mutations were introduced into the OptiTaq sequence using PCR site-directed mutagenesis (Weiner MP et al., Gene., 151(1-2):119-23 (1994)). Each mutagenesis reaction employed 10 pmol of two oligonucleotides (Table 38) to amplify around the plasmid containing the DNA polymerase, except for the 5' exonuclease domain. These primers were manufactured to contain a 5' phosphate to allow for religation after amplification. Briefly, these primers were annealed to double-stranded plasmids containing previously characterized mutant DNA polymerases (MUT ID2, 3, 10, 18, 21 and 30) (20 ng each), 5U KOD DNA polymerase (Novagen-EMD Chemicals, San Diego, CA), 1.5 mM MgSO4 in 1× KOD PCR buffer. Thermal cycling parameters were 95°C for 3 min (25 cycles of 95°C for 20 s, -55°C for 20 s, -70°C for 2 min), followed by a 4 min soak at 70°C. After PCR site-directed mutagenesis, the amplified products were treated with 10 U of DpnI (NEB, Ipswich, MA) for 1 h at 37°C, followed by inactivation at 80°C for 20 min. One-sixth of the digested material was ligated with T4 DNA ligase (NEB, Ipswich, MA) for 20 min at 16°C, followed by inactivation at 65°C for 10 min.One-fifteenth of the ligated digested material was transformed into XL-1 Blue competent bacteria. Bacterial clones were isolated, plasmid DNA was prepared, and the deletion of the 5' exonuclease domain was confirmed by Sanger DNA sequencing. All mutants were retained in the pET-27b(+) expression vector suitable for expressing recombinant proteins in E. coli. Expression and purification of the recombinant mutants of Taq polymerase was performed as described in Example 3.

[0289] [Table 38]

[0290] [Example 19] Characterization of the properties of seven 5'-exonuclease-deficient mutant Taq DNA polymerases in PCR. The seven mutant Taq DNA polymerase enzymes described in Example 18 were characterized for polymerase activity.

[0291] The unit activity of the purified wild-type protein was determined by comparing the performance in qPCR of known amounts of OptiTaq and each mutant compared to a commercially available non-hot start Taq DNA polymerase, Taq-B DNA polymerase (Enzymatics, Beverly, MA). Quantitation cycle values ​​(Cq, the amplification cycle number at which a positive signal is first detected) and amplification curve shapes were analyzed to determine the nanogram amounts at which both enzymes performed similarly within the suboptimal range for each. Using these nanogram amounts and the known unit values ​​for Taq-B DNA polymerase, relative activity unit values ​​could be extrapolated to all of the mutant DNA polymerase enzymes that had sufficient activity to support PCR. Tests were also performed to determine the MgCl2 concentration at which the polymerases showed optimal activity.

[0292] The following reaction conditions were employed: 1× qPCR buffer (20 mM Tris pH 8.4, 50 mM KCl, 0.01% Triton-X100) in a final volume of 10 μL, 800 μM dNTPs (200 μM each), 500 nM For primer (Hs HPRT F517, SEQ ID NO: 43), 500 nM Rev primer (Hs HPRT R591, SEQ ID NO: 44), 250 nM RNase H2 cleavable probe (Hs HPRT RN2 probe, SEQ ID NO: 164), 20 mU Pyrococcus abyssi RNase H2, 2× 10 3 copy linear cloned plasmid template (HPRT-targ, SEQ ID NO: 46). MgCl2 was tested at 3, 4 or 5 mM in each case. The amount of DNA polymerase added to the respective reactions was varied as follows: for wild type (OptiTaq), reactions were set up using 10, 1, 0.1, 0.01, 0.001 U / μL (220, 22, 2.2, 0.22 or 0.022 ng of protein per 10 μL reaction). Mutant polymerases were run at similar concentrations. Those mutant enzymes showing polymerase activity were also titrated more finely and 220, 22, 10.6, 4.8, 2.2, 1.1, 0.48 and 0.22 ng of protein per 10 μL reaction were tested. Polymerase dilutions were made in enzyme dilution buffer (20 mM Tris pH 7.5, 100 mM NaCl, 1 mM DTT, 0.1% Triton-X100, 1 mg / mL BSA, 10% glycerol). Reactions were performed in 384-well format on a BIO-RAD CFX384™ Real-Time System (BIO-RAD, Hercules, CA) using the following cycling parameters: 95° C. for 30 seconds, followed by 60 cycles of [95° C. for 15 seconds, followed by 60° C. for 1 minute]. Detection was achieved using a fluorescence quenched probe (cleaved by the action of the PaRNase H2 enzyme). The sequences of the primers, probes and templates (plasmid inserts) are shown in Table 39.

[0293] [Table 39] TIFF0007640606000095.tif63157

[0294] These seven Taq DNA polymerase 5'-exonuclease deletion mutants were characterized as outlined above. The results are summarized in Table 40. All seven mutants had DNA polymerase activity; however, processivity in mutants ID38, 39, 40, 41, 42 and 43 was reduced 10-50 fold compared to the wild-type enzyme. One mutant, ID37 (OptiTaq KlenTaq), showed DNA polymerase activity that was nearly identical to wild-type OptiTaq. Thus, the combination of complete deletion of the 5'-exonuclease domain of Taq DNA polymerase together with point mutations that improve polymerase specificity all significantly impaired enzyme activity and processivity.

[0295] [Table 40]

[0296] [Example 20] Improved mismatch discrimination in allele-specific PCR using mutant Taq DNA polymerases that also have a deletion of the 5'-exonuclease domain Of the seven mutant enzymes studied in Examples 18 and 19, mutants ID37, 38, 39, 40, 41, 42 and 43 retained sufficient enzymatic activity / processivity to be characterized. These seven mutants were studied for their ability to discriminate 3'-terminal DNA mismatches compared to wild-type OptiTaq DNA polymerase using an allele-specific qPCR assay. Amplification reactions were performed on synthetic oligonucleotide templates, in this case with a single base change (SNP) placed at the 3'-end of the reverse primer. Synthetic templates with each of the four possible bases at this position were employed. Reverse primers with each of the four possible bases at the 3'-end were employed. Relative amplification efficiencies were assessed using qPCR.

[0297] Quantitative allele-specific real-time PCR (AS-qPCR) yielded 2 × 10 5 The reactions were carried out in 10 μL reaction volumes in a 384-well format using a 103 bp synthetic template (SEQ ID NO:51-54) of 10 copies. The final reaction conditions used were 20 mM Tris-HCL (pH 8.4 at 25° C.), 50 mM KCL, the amount of MgCl2 determined to be optimal for each polymerase in Example 19, 0.01% Triton X-100, 800 μM total dNTPs, as well as 200 nM of the universal forward primer (SEQ ID NO:60), 200 nM of the reverse primer (separate reactions were set up for each of the allele-specific primers SEQ ID NO:55-58 or the control universal primer SEQ ID NO:59), and 200 nM of the RNase H2 cleavable probe (SEQ ID NO:165). Also included in each reaction was 20 mU of Pyrococcus abyssi RNase H2. Each allele-specific primer was tested on its respective SNP template. Reactions utilized either 0.5 U (10.8 ng / 11.1 nM / 111 fmol) of OptiTaq KlenTaq DNA polymerase (mutant ID37) or 0.5 U of one of the six Taq DNA polymerase mutants studied (mutant ID38 (108 ng / 111 nM / 1110 fmol); mutant ID39 (216 ng / 222 nM / 2220 fmol); mutant ID40 (360 ng / 370 nM / 3700 ​​fmol); mutant ID41 (1060 ng / 555 nM / 5550 fmol); mutant ID42 (1060 ng / 555 nM / 5550 fmol); mutant ID43 (216 ng / 222 nM / 2220 fmol)). Amplification was performed on a CFX384™ C1000™ Thermocycler System (Bio-Rad, Hercules, Calif.) using the following cycling parameters: initial denaturation at 95° C. for 30 seconds, followed by 60 cycles of 95° C. for 10 seconds, followed by 60 cycles of 60° C. for 30 seconds. The oligonucleotide reagents used in this example are shown in Table 41.

[0298] [Table 41] TIFF0007640606000098.tif126157

[0299] Initially, all reactions were performed in triplicate. Similar results were obtained for all replicates when wild-type OptiTaq was used. However, the results showed a greater variation for the mutant polymerase. Therefore, to obtain statistically meaningful results, each reaction was performed 24 times for the mutant polymerase and 21 times for the wild-type enzyme. ΔCq values ​​were calculated as the Cq value obtained for each mismatched base pair minus the Cq value obtained for the matched base pair (ΔCq=Cqmismatch-Cqmatch). The ΔCq values ​​for all 24 replicates were averaged and the standard deviation was calculated. The results are shown in Table 42 and summarized graphically in Figures 7A, 7B and 7C. Note that the reverse primer is an allele-specific primer. Thus, the "Syn Rev T" primer (SEQ ID NO:55) is a perfect match for template A (SEQ ID NO:51), and so on.

[0300] [Table 42] TIFF0007640606000100.tif231164TIFF0007640606000101.tif113163

[0301] The OptiTaq KlenTaq mutant ID37 showed an average ΔCq for AS-qPCR in this synthetic amplicon system of 9.8 with a range of 3.9 to 14.7. The mutant ID38 (A661E, I665W, F667L KlenTaq) showed an average ΔCq of 11.9 with a range of 7.9 to 17.4. The mutant ID39 (V783F KlenTaq) showed an average ΔCq of 11.3 with a range of 6.9 to 17.1. The mutant ID40 (H784Q KlenTaq) showed an average ΔCq of 11.9 with a range of 7.9 to 18.2. The mutant ID41 (V783L H784Q KlenTaq) showed an average ΔCq of 10.5 with a range of 5.8 to 15.8. Mutant ID42 (H784S KlenTaq) showed an average ΔCq of 11.9 with a range of 8.3 to 15.8. Mutant ID43 (H784Y KlenTaq) showed an average ΔCq of 11.2 with a range of 6.5 to 15.5. Thus, in all pairwise combinations of the four template bases and the four 3'-end primer bases, the mutant Taq DNA polymerases of the invention showed greater discrimination against mismatches than OptiTaq or OptiTaq KlenTaq DNA polymerases. The magnitude of improvement for each mismatch pair is defined by ΔΔCq, which is the difference in discrimination between the mutant and wild-type KlenTaq enzymes (ΔΔCq=ΔCqMutantKlenTaq-ΔCqOptiTaqKlenTaq). ΔΔCq values ​​were calculated and are shown in Table 43.

[0302] [Table 43] TIFF0007640606000103.tif209167

[0303] Mutant ID38 (A661E, I665W, F667L KlenTaq) showed a mean ΔΔCq of 1.7 compared to OptiTaq KlenTaq. Mutant ID39 (V783F KlenTaq) showed a mean ΔΔCq of 2.0 compared to OptiTaq KlenTaq. Mutant ID40 (H784Q KlenTaq) showed a mean ΔΔCq of 2.1 compared to OptiTaq KlenTaq. Mutant ID41 (V783L H784Q KlenTaq) showed a mean ΔΔCq of 0.7 compared to OptiTaq KlenTaq. Mutant ID42 (V784S KlenTaq) showed a mean ΔΔCq of 2.1 compared to OptiTaq KlenTaq. Mutant ID43 (H784Y KlenTaq) showed an average ΔΔCq of 2.0 compared to OptiTaq KlenTaq. Thus, each of the mutant Taq DNA polymerases of the present invention showed significant improvement in mismatch discrimination compared to OptiTaq KlenTaq, which has a complete deletion of the 5'-exonuclease domain but does not contain any other secondary mutations. Overall, mutants ID40 and 42 (H784Q KlenTaq and H784S KlenTaq) showed the best SNP discrimination within the set of mutant enzymes studied in this example using the AS-PCR assay.

[0304] [Example 21] Improved mismatch discrimination in rhPCR using mutant KlenTaq DNA polymerase in human genomic DNA SNP assays Example 20 demonstrated the utility of the novel mutant Taq DNA polymerase of the present invention in a synthetic amplicon rhPCR SNP discrimination assay system. This example demonstrated the utility of the novel mutant Taq DNA polymerase in a human genomic DNA rhPCR SNP discrimination assay system to investigate a SNP site in the SMAD7 gene (NM_005904, C / T SNP, rs4939827). The assay employed target DNA GM18562 (homozygous C / C) and GM18537 (homozygous T / T) from the Coriell Institute for Medical Research (Camden, NJ, USA). One blocked cleavable primer design, the generation 1 (Gen1) "RDDDDx" primer (see U.S. Patent Application No. 2012 / 0258455 by Behlke et al., entitled RNASE H-BASED ASSAYS UTILIZING MODIFIED RNA MONOMERS), was tested.

[0305] Quantitative real-time rhPCR was performed in a 10 μL reaction volume in a 384-well format containing 20 ng (corresponding to 6600 copies of target) of human genomic DNA (GM18562 or GM18537). Reactions utilized either 0.5 U (10.8 ng / 11.1 nM / 111 fmol) of OptiTaq KlenTaq DNA polymerase or 0.5 U of one of three Taq DNA polymerase mutants (mutant ID40 (360 ng / 370 nM / 3700 ​​fmol); mutant ID41 (1060 ng / 555 nM / 5550 fmol); mutant ID43 (216 ng / 222 nM / 2220 fmol)). The final reaction conditions used were 20 mM Tris-HCL (pH 8.4 at 25° C.), 50 mM KCL, 3 mM MgCl2, 0.01% Triton X-100, 800 μM total dNTPs, 200 nM forward primer (SEQ ID NO: 75-79), 200 nM universal reverse primer (SEQ ID NO: 74) and 200 nM RNase H2-cleavable SMAD7 probe (SEQ ID NO: 166). The 85 bp SMAD7 amplicon is shown as SEQ ID NO: 81. Forward primers included RDDDDx-configured Gen1 allele-specific rhPCR primers (SEQ ID NO: 76 and 77), and a non-allele specific control universal forward primer (SEQ ID NO: 75). The oligonucleotide reagents employed in this example are shown in Table 44. Reactions included 1 μL of PaRNase H2 at a concentration of 2.6 mU (5 fmole, 0.5 nM) per 10 μL reaction. Amplification was performed on a Roche LightCycler® 480 (Roche Applied Science, Indianapolis, IN, USA) as follows: 95° C. for 3 min, followed by 95 cycles of 95° C. for 10 s and 60° C. for 30 s. All reactions were performed in triplicate.

[0306] [Table 44]

[0307] The results using Gen1 RDDDDx rhPCR primers are shown in Table 45. The use of mutant Taq DNA polymerase showed significant improvement in SNP discrimination in this human genomic DNA rhPCR assay using Gen1 RDDDDx primers, but the amplification efficiency was often decreased, as indicated by the increase in match Cq. Thus, the use of novel mutant KlenTaq DNA polymerase improves SNP discrimination in rhPCR genotyping assays.

[0308] [Table 45]

[0309] [Example 22] Sequences of Taq DNA polymerase mutants that exhibit improved discrimination against mismatches or the presence of an RNA residue at the 3' end of the primer. The complete amino acid and nucleotide sequences of the codon-optimized mutant enzymes employed in Examples 18-21 are shown below. These sequences can be readily derived by one of skill in the art from the information provided in Tables 1, 3, 4, 26 and 38, but for clarity, the final assembled sequences are provided. Base changes are identified in bold underlined font for nucleic acid and amino acid substitutions.

[0310] SEQ ID NO: 167, nucleotide sequence of mutant ID37 (OptiTaq KlenTaq).

[0311] [ka]

[0312] SEQ ID NO: 168, amino acid sequence of mutant ID37 (OptiTaq KlenTaq).

[0313] [ka]

[0314] SEQ ID NO:169, nucleotide sequence of mutant ID38 (A661E, I665W, F667L KlenTaq).

[0315] [ka]

[0316] SEQ ID NO: 170, amino acid sequence of mutant ID38 (A661E, I665W, F667L KlenTaq).

[0317] [ka]

[0318] SEQ ID NO:171, nucleotide sequence of mutant ID39 (V783F KlenTaq).

[0319] [ka] TIFF0007640606000111.tif42157

[0320] SEQ ID NO: 172, amino acid sequence of mutant ID39 (V783F KlenTaq).

[0321] [ka]

[0322] SEQ ID NO:173, nucleotide sequence of mutant ID40 (H784Q KlenTaq).

[0323] [ka]

[0324] SEQ ID NO: 174, amino acid sequence of mutant ID40 (H784Q KlenTaq).

[0325] [ka]

[0326] SEQ ID NO:175, nucleotide sequence of mutant ID41 (V783L H784Q KlenTaq).

[0327] [ka]

[0328] SEQ ID NO: 176, amino acid sequence of mutant ID41 (V783L H784Q KlenTaq).

[0329] [ka]

[0330] SEQ ID NO:177, nucleotide sequence of mutant ID42 (H784S KlenTaq).

[0331] [ka]

[0332] SEQ ID NO: 178, amino acid sequence of mutant ID42 (H784S KlenTaq).

[0333] [ka]

[0334] SEQ ID NO:179, nucleotide sequence of mutant ID43 (H784Y KlenTaq).

[0335] [ka] TIFF0007640606000120.tif53155

[0336] SEQ ID NO: 180, amino acid sequence of mutant ID43 (H784Y KlenTaq).

[0337] [ka]

[0338] Incorporation by Reference All publications, patents, patent applications, and accession number data described herein are incorporated herein by reference in their entirety, as if each individual publication, patent, patent application, or accession number data was specifically and individually indicated to be incorporated by reference. In the case of citation and reference to accession number data, the corresponding DNA polymerase amino acid sequence and nucleotide sequence are incorporated herein by reference as if such sequences were disclosed by SEQ ID NO. In case of conflict, the present application, including any definitions herein, will control.

[0339] The terms used herein are for the purpose of describing specific embodiments only and are not intended to be limiting. With respect to the use of virtually any plural and / or singular terms herein, those skilled in the art can translate from the plural as appropriate to the context and / or application. Various singular / plural permutations may be expressly set forth herein for clarity.

[0340] Although the invention has been described with reference to specific embodiments, it will be understood by those skilled in the art that various changes can be made and equivalents may be substituted without departing from the scope of the invention. In addition, many modifications may be made to adapt a particular situation or material to the teachings of the invention without departing from its scope. Therefore, it is not intended that the invention be limited to the particular embodiments or examples disclosed, but rather the invention is intended to include all embodiments falling within the scope of the appended claims.

Claims

1. A mutant Taq DNA polymerase having increased template discrimination activity compared to an unmodified Taq DNA polymerase, wherein the amino acid sequence of the mutant Taq DNA polymerase comprises the following substitutions: H784Q or a combination of V783L and H784Q, and the amino acid sequence of the mutant Taq DNA polymerase has at least 95% sequence identity to one of SEQ ID NOs: 85 or 89.

2. 2. The mutant Taq DNA polymerase of claim 1, wherein the increased template discrimination activity comprises at least one property selected from the group consisting of increased 3'-mismatch discrimination and increased 3'-nucleotide discrimination.

3. 2. The mutant Taq DNA polymerase of claim 1, further comprising a polymerase activity at least equal to about 0.02-fold the polymerase activity of unmodified Taq DNA polymerase.

4. 2. The mutant Taq DNA polymerase of claim 1, wherein the increased template discrimination activity comprises increased 3'-mismatch discrimination, and when the mutant Taq DNA polymerase is assessed for increased 3'-mismatch discrimination by an allele-specific PCR assay, the average ΔΔCq is at least about 5.

0.

5. 2. The mutant Taq DNA polymerase of claim 1, wherein the increased template discrimination activity comprises increased 3'-nucleotide discrimination, and when the mutant Taq DNA polymerase is assessed for increased 3'-nucleotide discrimination by quantitative PCR, the average ΔΔCq is at least about 3.

0.

6. 2. The mutant Taq DNA polymerase of claim 1, wherein the increased template discrimination activity comprises increased 3'-mismatch discrimination, and when the mutant Taq DNA polymerase is assessed for increased 3'-mismatch discrimination by rhPCR with RDDDDx blocked-cleavable rhPCR primers, the average ΔΔCq is at least about 1.

0.

7. 2. The mutant Taq DNA polymerase of claim 1, wherein the increased template discrimination activity comprises increased 3'-mismatch discrimination, and when the mutant Taq DNA polymerase is assessed for increased 3'-mismatch discrimination by rhPCR with RDxxD blocked-cleavable rhPCR primers, the average ΔΔCq is at least about 0.

60.

8. 2. The mutant Taq DNA polymerase of claim 1, wherein the increased template discrimination activity comprises increased 3'-mismatch discrimination by rhPCR SNP discrimination assay, and wherein the mutant Taq DNA polymerase has an average ΔΔCq of at least about 1.0 when assessed for increased 3'-mismatch discrimination by rhPCR SNP discrimination assay of SMAD7 gene (NM_005904, C / T SNP, rs4939827) using RDDDDx blocked-cleavable rhPCR primers consisting of SEQ ID NOs:76 and 77.

9. 2. The mutant Taq DNA polymerase of claim 1, wherein the increased template discrimination activity comprises increased 3'-mismatch discrimination by rhPCR SNP discrimination assay, and wherein the mutant Taq DNA polymerase has an average ΔΔCq of at least about 3.5 when assessed for increased 3'-mismatch discrimination by rhPCR SNP discrimination assay of SMAD7 gene (NM_005904, C / T SNP, rs4939827) using RDxxD blocked-cleavable rhPCR primers consisting of SEQ ID NOs:78 and 79.

10. 2. The mutant Taq DNA polymerase of claim 1, wherein the increased template discrimination activity comprises increased 3'-mismatch discrimination by rhPCR SNP discrimination assay, and wherein the mutant Taq DNA polymerase has an average ΔΔCq of at least about 15.0 when assessed for increased 3'-mismatch discrimination by rhPCR SNP discrimination assay of SMAD7 gene (NM_005904, C / T SNP, rs4939827) using RDxxD blocked-cleavable rhPCR primers consisting of SEQ ID NOs:78 and 79.

11. 2. The mutant Taq DNA polymerase of claim 1, wherein the increased template discrimination activity comprises increased low frequency allele discrimination, and the increased low frequency allele discrimination is at least 1:10,000 when assessed by an rhPCR SNP discrimination assay of the SMAD7 gene (NM_005904, C / T SNP, rs4939827) with a ΔCq of at least 3.0 using RDxxD blocked-cleavable rhPCR primers consisting of SEQ ID NOs:78 and 79.

12. 13. A kit for generating extended primers comprising at least one container providing the mutant DNA polymerase of claim 1.

13. 13. The kit of claim 12, further comprising one or more additional containers selected from the group consisting of: (a) a container providing a primer capable of hybridizing to a predetermined polynucleotide template under primer extension conditions; (b) a container providing nucleoside triphosphates; and (c) a container providing a buffer suitable for primer extension.

14. 13. The kit of claim 12, further comprising one or more additional containers selected from the group consisting of: (a) a container containing a blocked-cleavable primer, and (b) a container containing RNase H2.

15. 10. A reaction mixture comprising the mutant DNA polymerase of claim 1, at least one primer, a polynucleotide template and nucleoside triphosphates.

16. 16. The reaction mixture of claim 15, wherein at least one primer comprises a blocked-cleavable primer.

17. 16. The reaction mixture of claim 15, further comprising RNase H2.

18. A mutant Taq DNA polymerase consisting of an amino acid sequence selected from the group consisting of SEQ ID NO:85, SEQ ID NO:89, SEQ ID NO:147, SEQ ID NO:149, SEQ ID NO:155, SEQ ID NO:151, SEQ ID NO:153, SEQ ID NO:157, SEQ ID NO:159, SEQ ID NO:161, SEQ ID NO:174, SEQ ID NO:176, SEQ ID NO:178 and SEQ ID NO:

180.

19. The mutant Taq DNA polymerase of claim 18, wherein the increased template discrimination activity comprises at least one property selected from the group consisting of increased 3'-mismatch discrimination and increased 3'-nucleotide discrimination.

20. The mutant Taq DNA polymerase of claim 18, further comprising a polymerase activity at least equal to about 0.02-fold the polymerase activity of unmodified Taq DNA polymerase.

21. The mutant Taq DNA polymerase of claim 18, wherein the increased template discrimination activity comprises increased 3'-mismatch discrimination, and when the mutant Taq DNA polymerase is assessed for increased 3'-mismatch discrimination by an allele-specific PCR assay, the average ΔΔCq is at least about 5.

0.

22. The mutant Taq DNA polymerase of claim 18, wherein the increased template discrimination activity comprises increased 3'-nucleotide discrimination, and when the mutant Taq DNA polymerase is assessed for increased 3'-nucleotide discrimination by quantitative PCR, the average ΔΔCq is at least about 3.

0.

23. The mutant Taq DNA polymerase of claim 18, wherein the increased template discrimination activity comprises increased 3'-mismatch discrimination, and when the mutant Taq DNA polymerase is assessed for increased 3'-mismatch discrimination by rhPCR using RDDDDx blocked-cleavable rhPCR primers, the average ΔΔCq is at least about 1.

0.

24. The mutant Taq DNA polymerase of claim 18, wherein the increased template discrimination activity comprises increased 3'-mismatch discrimination, and when the mutant Taq DNA polymerase is assessed for increased 3'-mismatch discrimination by rhPCR using RDxxD blocked-cleavable rhPCR primers, the average ΔΔCq is at least about 0.

60.

25. The mutant Taq DNA polymerase of claim 18, wherein the increased template discrimination activity comprises increased 3'-mismatch discrimination by rhPCR SNP discrimination assay, and wherein the mutant Taq DNA polymerase has an average ΔΔCq of at least about 1.0 when assessed for increased 3'-mismatch discrimination by rhPCR SNP discrimination assay of the SMAD7 gene (NM_005904, C / T SNP, rs4939827) using RDDDDx blocked-cleavable rhPCR primers consisting of SEQ ID NOs:76 and 77.

26. The mutant Taq DNA polymerase of claim 18, wherein the increased template discrimination activity comprises increased 3'-mismatch discrimination by rhPCR SNP discrimination assay, and wherein the mutant Taq DNA polymerase has an average ΔΔCq of at least about 3.5 when assessed for increased 3'-mismatch discrimination by rhPCR SNP discrimination assay of the SMAD7 gene (NM_005904, C / T SNP, rs4939827) using RDxxD blocked-cleavable rhPCR primers consisting of SEQ ID NOs:78 and 79.

27. The mutant Taq DNA polymerase of claim 18, wherein the increased template discrimination activity comprises increased 3'-mismatch discrimination by rhPCR SNP discrimination assay, and wherein the mutant Taq DNA polymerase has an average ΔΔCq of at least about 15.0 when assessed for increased 3'-mismatch discrimination by rhPCR SNP discrimination assay of the SMAD7 gene (NM_005904, C / T SNP, rs4939827) using RDxxD blocked-cleavable rhPCR primers consisting of SEQ ID NOs:78 and 79.

28. The mutant Taq DNA polymerase of claim 18, wherein the increased template discrimination activity comprises increased low frequency allele discrimination, and wherein the increased low frequency allele discrimination is at least 1:10,000 when the mutant Taq DNA polymerase is assessed by an rhPCR SNP discrimination assay of the SMAD7 gene (NM_005904, C / T SNP, rs4939827) with a ΔCq of at least 3.0 using RDxxD blocked-cleavable rhPCR primers consisting of SEQ ID NOs:78 and 79.

29. A kit for generating extended primers comprising at least one container providing a mutant DNA polymerase according to claim 18.

30. The kit of claim 29, further comprising one or more additional containers selected from the group consisting of: (a) a container providing a primer capable of hybridizing to a predetermined polynucleotide template under primer extension conditions; (b) a container providing a nucleoside triphosphate; and (c) a container providing a buffer suitable for primer extension.

31. The kit of claim 29, further comprising one or more additional containers selected from the group consisting of: (a) a container containing a blocked-cleavable primer; and (b) a container containing RNase H2.

32. A reaction mixture comprising the mutant DNA polymerase of claim 18, at least one primer, a polynucleotide template and nucleoside triphosphates.

33. The reaction mixture of claim 32, wherein at least one primer comprises a blocked-cleavable primer.

34. The reaction mixture of claim 32, further comprising RNase H2.

Images